Catalog Pro5® MHC Class I Pentamers

Catalog Pro5® MHC Class I Pentamers

Pentamer Research Areas – Select a disease area to view publications demonstrating the use of Pentamers

AAVAdenovirusAutoimmunityBK Virus
CancerChlamydiaCMVCOVID-19 / SARS-CoV-2
DengueEBVHAVHBV
HCVHIV/SIVHPVHSV
HTLVInfluenzaJC VirusLCMV
ListeriaMalariaMiHAgModel Antigens
MuLVNegativeNorovirusOther
RabiesRSVSendai VirusSV40 Virus
Toxoplasma gondiiTrypanosomaTuberculosisVaccinia
Varicella Zoster VirusVSVWest Nile VirusYellow Fever Virus

Search the table below by disease, allele, specificity or sequence, or any combination, e.g. “CMV A*02:01 pp65”. If your specificity is not listed, we can synthesize Custom MHC Class I Pentamers at no additional cost.

DISEASEALLELEPEPTIDE CODEPEPTIDE SEQUENCEEPITOPE ORIGIN
AAVA*01:01886SADNNNSEYAAV VP1 492-500
AAVB*07:02651VPQYGYLTLAAV2 372-380
AAVH-2KdKYLGPFNGLcapsid protein 51-59
AdenovirusA*01:01686TDLGQNLLYAdenovirus 5 Hexon 886-894
AdenovirusA*02:01YVLFEVFDVVHexon major capsid protein 916–925
AdenovirusA*24:02684TYFSLNNKFAdenovirus 5 Hexon 37-45
AdenovirusB*07:02685KPYSGTAYNSLAdV Hexon
AdenovirusB*07:02989KPYSGTAYNALAdenovirus Hexon 114-124
AdenovirusB*35:011346IPYLDGTFYAdV Hexon
AdenovirusH-2Db2206SGPSNTPPEIAd5 E1A 234-243
AdenovirusH-2DbVNIRNCCYIE1B protein 192-200
AutoImmunityA*02:01151KLQVFLIVLT1D Diabetes human prepro islet amyloid polypeptide ppIAPP 5-13
AutoImmunityA*02:01393VMNILLQYVGAD65 114-123
AutoImmunityA*02:01470SLSRFSWGAMyelin basic protein 110-118
AutoImmunityA*02:01851HLVEALYLVInsulin B chain 10-18
AutoImmunityA*02:01954LNIDLLWSVT1D Diabetes IGRP 228-236
AutoimmunityA*02:011904VLFGLGFAIT1D Diabetes IGRP 265-273
AutoimmunityA*02:012259ALWGPDPAAAProinsulin precursor 15-24
AutoimmunityA*02:012382MVWESGCTVIA-2 797-805
AutoimmunityA*02:013342YTCPLCRAPVSSA SS-56 55-64
AutoimmunityA*02:013394VIVMLTPLVIA-2 805-813
AutoimmunityA*02:01969RLLPLLALLInsulin Precursor 76-90
AutoimmunityA*02:01LLNATIAEVsteroid 21-hydroxylase (21OH) 342-350
AutoimmunityA*02:01LLIGGFAGLthyroperoxidase (TPO) 857-865
AutoimmunityA*02:01ALARWLPPVThyroid peroxidase 172-180
AutoimmunityA*02:01HIAGSLAVVZinc transporter 8 (ZnT-8) 93-101
AutoimmunityA*02:01FLALSILVLCalcitonin 9-17
AutoimmunityA*02:01ILLAELEQLVimentin 130-138
AutoimmunityA*02:01LLAGIGTVPIprostaglandin transporter (hPGT) / solute carrier protein (SLCO2A1) 178-187
AutoimmunityA*02:01SLDALITHVAlcohol dehydrogenase 1B (ADH1B) 342-350
AutoimmunityA*02:01GIIYIIYKLGenome polyprotein 1505-1513
AutoimmunityA*02:01KLKDVLLQVMyosin-9 1843-1851
AutoimmunityA*02:01FLLSLFSLWLZinc transporter 8 (ZnT-8) 114-123
AutoimmunityA*02:01RLLDLAQEGLCytochrome P450 2D6 (CYP2D6) 204-213
AutoimmunityA*02:01GLEALVPLAVCytochrome P450 2D6 (CYP2D6) 204-213
AutoimmunityA*02:01ILKDFSILLZinc transporter 8 (ZnT-8) 266-274
AutoimmunityA*02:01ALYDATYETCofilin-1 (CFL1) 83-91
AutoimmunityA*02:01KLANPLPYTspermine oxidase (SMOX)
AutoimmunityA*02:01GMVTTSTTLCytochrome P450 2D6 (CYP2D6) 304-314
AutoimmunityA*02:01KLSEGDLLApyruvate dehydrogenase complex subunit E2 (PDC-E2) 159-167
AutoimmunityA*03:01MVPFIPLYRTyrosinase 426–434
AutoimmunityA*03:01ALYLVCGERInsulin (38-46)
AutoimmunityA*29:02VTLTCAFRYRetinal S-antigen (SAG / Arrestin) 63-71
AutoimmunityB*07:02RPPGGSGPLLF-box only protein 7 (FBXO7) 3-12
AutoimmunityB*07:02APREPFAHSLZinc finger CCCH-type-containing protein 12D (ZC3H12D) 321-330
AutoimmunityB*08:01EPLARLEL21-hydroxylase (CYP21A2) 431-438
AutoimmunityB*27:05RRYQKSTELHistone H3.3 53-61
AutoimmunityB*27:05HRVYLVRKLHuman E3 ubiquitin-protein ligase RNF213 4275 to 4283
AutoimmunityB*27:05SRVLQNVAFbcl-2-related protein A1 isoform 1 34-42
AutoimmunityH-2Db1107RSPFSRVVHLMOG Precursor 69-78
AutoimmunityH-2DbRMLENYEEICullin-7 373-381
AutoimmunityH-2DbHAFENLEIIEpidermal growth factor receptor isoform 1 precursor 418-426
AutoimmunityH-2DbLSIQNYHVFLApolipoprotein B-100 4463-4472
AutoimmunityH-2DbYAASNGVLMOrnithine Decarboxylase (ODC)
AutoimmunityH-2DbNGVINAAFMPhosphatidylinositol-binding clathrin assembly protein (AP180) 190-198
AutoimmunityH-2DbISGVNRYYVNADH dehydrogenase (ubiquinone) 1 alpha subcomplex subunit 1 (NDUFA1) 54-62
AutoimmunityH-2DbSAVRLRSSVVimentin 66-74
AutoimmunityH-2KbSNYLFTKLendothelial PAS domain-containing protein 1 386-393
AutoimmunityH-2KbRTYTYEKLcatenin beta-1 329-336
AutoimmunityH-2KbVPYAFKSLApolipoprotein B-100 4281-4288
AutoimmunityH-2KbSSYTFPKMEnoyl-CoA delta isomerase 2 (EICI2) 280-287
AutoimmunityH-2KbVGPRYTNLmitogen-activated protein kinase 1 (Mapk1) 19-26
AutoimmunityH-2KbINFDFPKLProbable ATP-dependent RNA helicase DDX6 (p54 Rna Helicase) 407-414
AutoimmunityH-2KbRAYLFNSVyippee-like 1 (YPEL1) 47–54
AutoimmunityH-2KbKIITYRNLPCI domain-containing protein 2 318-325
AutoimmunityH-2KbVNQVYSTLApolipoprotein B-100 2533-2540
AutoimmunityH-2KbTNLKYSPLApolipoprotein B-100 1658-1665
AutoimmunityH-2KbVSFTYRYLvacuolar protein sorting 16 (VPS16) 227-234
AutoimmunityH-2KbKILTFDQL60S ribosomal protein L18 (RPL18) 119-126
AutoimmunityH-2KbVINPYKNLMyosin-9 (MYH9) 120-127
AutoimmunityH-2KbVAFDFTKVPhosphatidylinositol-binding clathrin assembly protein (PICALM) 141-148
AutoimmunityH-2KbVIVRFLTV40S ribosomal protein S15a (RPS15A) 33-40
AutoimmunityH-2KbHILIYSDVmyosin binding protein C 399-406
AutoimmunityH-2KdGYFEVTHDICatalase 83-91
AutoimmunityH-2KdHFLPMLQTVMyosin light polypeptide 6 (MYL6) 69-77
AutoimmunityH-2Kd
580VYLKTNVFLIGRP (206-214)
BK virusA*02:011516AITEVECFLVP1 44-52
BK virusA*02:011783FLHCIVFNVlarge T antigen 410-418
BK virusA*02:013781LLMWEAVTVVP1 108-116
BK virusA*02:013903CLLPKMDSVlarge T antigen 398-406
BK VirusA*11:01AVDTVLAKKLarge T antigen 342-350
BK virusB*07:022070LPLMRKAYLLT antigen 27-35
BK VirusB*07:02APKKPKEPVViral capsid protein 1 (VP1) 14-22
BK VirusB*07:02GPLCKADSLMajor capsid protein VP1 252-160
BK VirusB*07:02NPTAQSQVMVP1 182-190
BK VirusB*35:01EPLVWIDCYsmall t 129-137
CancerA*01:0129EADPTGHSYMAGE-A1 161-169
CancerA*01:0130EVDPIGHLYMAGE-A3 168-176
CancerA*01:01307KSDICTDEYTyrosinase 243-251 (244S)
CancerA*01:01467KCDICTDEYTyrosinase 243-251
CancerA*01:011542QSLEIISRYMcl-1 177-185
CancerA*01:012102YVDFREYEYYFLT3 ITD
CancerA*01:013383TLDTLTAFYMesothelin 429-437
CancerA*01:013622LTDDRLFTCYPLEKHM2
CancerA*01:013623DSDPDSFQDYTyr A1a 454-463
CancerA*01:013624EADPIGHLYMAGEA3
CancerA*01:013626EVDPASNTYMAGE-A4 169-177
CancerA*01:013627HSTNGVTRIYPSMA
CancerA*01:013628ILDTAGREEYN-ras 55-64
CancerA*01:013630LVDVMPWLQYCytochrome P450 240-249
CancerA*01:013632RSDSGQQARYAIM-2
CancerA*01:013633VTEPGTAQYMinor antigen HA-3T (Lbc oncogene 451-459)
CancerA*01:013634VYDFFVWLHYTRP-2 181-190
CancerA*01:01YTDSSSILNYUHRF1-binding protein 1-like 1004–1013
CancerA*01:01YSDKYGLGYPolo-like kinase 1 (PLK1) 417-425
CancerA*01:01ESDPIVAQYTitin 23410-23418
CancerA*01:01SSDYVIPIGTYTyrosinase 146-156
CancerA*01:01DSDSEEPSKYReceptor-type tyrosine-protein phosphatase C (PTPRC) 1008-1017
CancerA*01:01ILDTAGLEEYKRAS Q61L 55-64
CancerA*01:01ILDTAGKEEYNeuroblastoma RAS viral oncogene homolog (NRAS) Q61K 55-64
CancerA*01:01NSEEHSARYhighly similar to PX domain-containing protein kinase-like protein 441-449
CancerA*01:01ILDTAGQEEYKRAS 55-64
CancerA*01:01NLDKNLIKYReceptor-type tyrosine-protein phosphatase C 434-442
CancerA*01:01YVDILPYDYReceptor-type tyrosine-protein phosphatase C 683-691
cancerA*01:01LSHIHASSYPreferentially expressed antigen in melanoma 267-275
CancerA*02:0134FLWGPRALVMAGEA3 271-279
CancerA*02:0146IMDQVPFSVgp100 (pmel17) 209-217
CancerA*02:0147YLEPGPVTVgp100 (pmel) 280-288 (288V)
CancerA*02:0148YLSGADLNLCarcinoembryonic antigen (CEA)-derived peptide CAP1-6D
CancerA*02:0149SLLMWITQCNY-ESO-1 157-165 (9C)
CancerA*02:0157KTWGQYWQVgp100 (pmel17) 154-162
CancerA*02:0158YLEPGPVTAgp100
CancerA*02:0161YMDGTMSQVTyrosinase 369-377 (371D)
CancerA*02:0175YLSGANLNLCarcinogenic Embryonic Antigen (CEA) 571-579
CancerA*02:0182ELAGIGILTVMelanA / MART 26-35
CancerA*02:0185ILAKFLHWLTelomerase 540-548
CancerA*02:0186ALQPGTALLProstate Stem Cell Antigen (PSCA) 14-22
CancerA*02:0197VISNDVCAQVProstate Specific Antigen-1 (PSA-1) 154-163
CancerA*02:01117RLVDDFLLVTelomerase Reverse Transcriptase 865-873
CancerA*02:01125GVLVGVALICarcinogenic Embryonic Antigen (CEA) 694-702
CancerA*02:01157VLYRYGSFSVgp100 (pmel17) 476-485
CancerA*02:01162PLFQVPEPVAlpha-fetoprotein isoform 1 137-145
CancerA*02:01163FMNKFIYEIHuman alfa fetoprotein 158-166
CancerA*02:01164GLSPNLNRFLAlpha-fetoprotein isoform 2 167-176
CancerA*02:01171KVLEYVIKVMAGEA1 278-286
CancerA*02:01205LLGRNSFEVp53 264-272
CancerA*02:01208LLLLTVLTVMUC-1 12-20
CancerA*02:01210ILHNGAYSLHER-2/neu 435-443
CancerA*02:01212RLLQETELVHER-2/neu 689-697
CancerA*02:01214KIFGSLAFLHER-2/neu 369-377
CancerA*02:01220LLLLDVAPLHSP1A 459-467
CancerA*02:01221LLDVAPLSLHSP1A 461-469
CancerA*02:01226HLYQGCQVVReceptor tyrosine-protein kinase erbB-2 48-56
CancerA*02:01249HLSTAFARVG250 (renal cell carcinoma) 217-225
CancerA*02:01250VLQELNVTVLeukocyte Proteinase-3 (Wegener's autoantigen) 169-177
CancerA*02:01302KVAELVHFLMAGEA3 112-120
CancerA*02:01304VLAGVGFFIEPHA2 550-558
CancerA*02:01306FLYTLLREVSTEAP 86-94
CancerA*02:01329ILLWQPIPVProstatic Acid Phosphatase-3 (PAP-3) 135-143
CancerA*02:01337RLQEERTCKVBIR
CancerA*02:01338QLCPICRAPVLivin/ML-IAP280 175-184
CancerA*02:01345VLGEAWRDQVTRAP 45-54
CancerA*02:01381LLLTVLTVVTumor Mucin Antigen 13-21
CancerA*02:01389GLYDGMEHLMAGEA-10 254-262
CancerA*02:01390SLLMWITQVNY-ESO-1 157-165
CancerA*02:01391LMLGEFLKLSurvivin 96-104
CancerA*02:01394YLFFYRKSVmTERT 572-580
CancerA*02:01404FLTPKKLQCVProstate Specific Antigen-1 (PSA-1) 141-150
CancerA*02:01405KLQCVDLHVProstate Specific Antigen 146-154
CancerA*02:01408TLAPATEPAMucin 79-87
CancerA*02:01447YLQVNSLQTVTelomerase Reverse Transcriptase (hTRT) 988-997
CancerA*02:01452SLGEQQYSVWT1 187-195
CancerA*02:01457SLEENIVILRHAMM 275-283
CancerA*02:01464YMNGTMSQVTyrosinase 368-376
CancerA*02:01468ILSLELMKLReceptor for hyaluronic acid-mediated
motility (RHAMM) 165-173
CancerA*02:01480PLFDFSWLSLBcl-2 208-217
CancerA*02:01516LLGATCMFVCyclinD 101-109
CancerA*02:01527ALYVDSLFFLPRAME PRA 300-309
CancerA*02:01560GLMEEMSALHuman Mena protein (overexpressed in breast cancer)
CancerA*02:01561TMNGSKSPVhMena 502-510
CancerA*02:01575GVYDGREHTVMAGE-A4 230-239
CancerA*02:01594YLNDHLEPWIBcl-X 173-182
CancerA*02:01599ALDVYNGLLProstatic acid phosphatase precursor (PAP) 299-307
CancerA*02:01600ALFDIESKVPSM P2 (prostate)
CancerA*02:01637SLAMLDLLHVMutant anaplastic lymphoma kinase 1220-1229
CancerA*02:01645YLNTVQPTCVEGF-R 1138-1147
CancerA*02:01646KLFGTSGQKTEGF-R-479 350-359
CancerA*02:01654RMPEAAPPVp53 65-73
CancerA*02:01655KLVVVGADGVKRAS G12D (5-14)
CancerA*02:01752KLVVVGAVGVKRAS G12V (5-14)
CancerA*02:01662PLTSIISAVReceptor tyrosine-protein kinase erbB-2 728-736
CancerA*02:01689VLAGGFFLLPSMA 27-38
CancerA*02:01690LLHETDSAVPSMA/PSM-P1 4-12
CancerA*02:01693VMAGVGSPYVReceptor tyrosine-protein kinase erbB-2 819-828
CancerA*02:01773VLPLTVAEVMesothelin 530-538
CancerA*02:01774SLLFLLFSLMesothelin 20-28
CancerA*02:01780QLFEELQELHeme oxygenase-1 212-220
CancerA*02:01781VLDGLDVLLPRAME 100-108
CancerA*02:01787RLASFYDWPLBIR7 90-99
CancerA*02:01810LIAHNQVRQVHER-2/neu (85-94)
CancerA*02:01811ILHDGAYSLHER-2 434-443
CancerA*02:01813FVGEFFTDVGPC3 144-152 (overexpressed in hepatocellular carcinoma)
CancerA*02:01841LLLIWFRPVBKV Ltag 579-587
CancerA*02:01859KLQDASAEVHM1.24-aa 126-134
CancerA*02:01861SLLQHLIGLPRAME 425-433
CancerA*02:01862VIFDFLHCIBKV Ltag 406-414
CancerA*02:01893VLDFAPPGAWT1
CancerA*02:01915TLPGYPPHVPAX-5 311-319
CancerA*02:01921YMEHNNVYTVFibromodulin 250-259
CancerA*02:01922YLQHNEIQEVFibromodulin 206-215
CancerA*02:01958SLVDVMPWLCytochrome p450 1B1 239-248
CancerA*02:01960RLMNDMTAVHSP105 128-136
CancerA*02:01997RLARLALVLTrophoblast glycoprotein 17-25
CancerA*02:01998FLTGNQLAV5T4 97-105
CancerA*02:011007LLLAGLFSLFibromodulin 7-15
CancerA*02:011013FLGYLILGVProstatic Acid Phosphatase-3 (PAP-3)
CancerA*02:011056SLFLGILSVCD20 188-196 (B cell malignancies)
CancerA*02:011130AVLPLLELVMCL-1 139-147
CancerA*02:011181SLSEKTVLLCD59 glycoprotein precursor 106-114
CancerA*02:011201YMCSFLFNLEwing Tumor EZH2 666-674
CancerA*02:011239YLISGDSPVCD33 65-73 (1Y2L)
CancerA*02:011246KASEKIFYVSSX2 41-49
CancerA*02:011302FLAKLNNTVHCA587 317-325
CancerA*02:011386GLAPPQHLIRVp53 187-197
CancerA*02:011403VIMPCSWWVChondromodulin-I 319-327
CancerA*02:011421KVVEFLAMLMAGE-C1 1083-1091
CancerA*02:011464LTLGEFLKLSurvivin-3A 96-104
CancerA*02:011508ALPFGFILVIL13R 345-353
CancerA*02:011509TLADFDPRVEphA2
CancerA*02:011778ALMEQQHYVITGB8 662-670
CancerA*02:011779CLTSTVQLVHER-2/neu 789-797
CancerA*02:011786GLLGASVLGLTelomerase Reverse Transcriptase (hTRT) 674-683
CancerA*02:011908QLLDGFMITLPASD1 39-48
CancerA*02:011910YLVGNVCILPASD1 168-176
CancerA*02:011920ALLTSRLRFITelomerase Reverse Transcriptase (hTRT) 615-624
CancerA*02:011937RLSSCVPVA131-139
CancerA*02:012079FLYDDNQRVTopoisomerase II-alpha-b 828-836
CancerA*02:012081YLIELIDRVTACE 250-258
CancerA*02:012083FLAEDALNTVEpithelial Discoidin Domain Receptor 1 (EDDR1) 867-876
CancerA*02:012236GLMKYIGEVTRPM8 187-195
CancerA*02:012291AILALLPALProstate Stem Cell Antigen (PSCA) 105-133
CancerA*02:012293GLQHWVPELBA46 (Lactadherin) 97-106
CancerA*02:012294GVRGRVEEIBCR-ABL
CancerA*02:012296ITDQVPFSVgp100 (pmel) 209-217
CancerA*02:012297KLCPVQLWVp53 139-147
CancerA*02:012298KVAEELVHFLMAGEA3 112-120 (alternative version)
CancerA*02:012299SLPPPGTRVp53 149-157
CancerA*02:012300YLGSYGFRLp53 103-111
CancerA*02:012301YLQLVFGIEVMAGEA2 157-166
CancerA*02:012371TLQDIVYKLBMI1 74-82
CancerA*02:012457YAIDLPVSVL-dopachrome tautomerase 488-496
CancerA*02:012569AMVGAVLTATyrosinase 482-190
CancerA*02:012582ATVGIMIGVCEACAM5 687-695
CancerA*02:012649YVDPVITSIHepatocyte growth factor receptor 673-681
CancerA*02:012669GVLLWEIFSLVEGFR1 28-37
CancerA*02:012778GLSNLTHVLPRAME (432-440)
CancerA*02:012793LMAQEALAFLCAMEL 2-11
CancerA*02:012860ALLPAVPSLWilms Tumor Protein 83-91
CancerA*02:012988RVA(PHOSPHO-S)PTSGVInsulin receptor substrate-2 1097-1105
CancerA*02:012990RVASPTSGVIRS-2 1097-1105
CancerA*02:013006KVDELAHFLMelanoma-associated antigen 4 (MAGE4) 113-121
CancerA*02:013080KVLEHVVRVMelanoma-associated antigen 4 (MAGE4) 286-294
CancerA*02:013343ALNVYNGLLACPP 299-307
CancerA*02:013344ALSPVPPVVBcl-2 85-93
CancerA*02:013345ALVCYGPGIFAP alpha 463-471
CancerA*02:013346ALWPWLLMATRNF43 11-20
CancerA*02:013347ALYLMELTMCB9L2
CancerA*02:013350CLPSPSTPVBMI1 271-279
CancerA*02:013352ELSDSLGPVPASD1 695-703
CancerA*02:013355FLFLRNFSLTARP(V28L)27-35
CancerA*02:013356FLPSPLFFFLTARP(P5L) 5-13
CancerA*02:013357GLFKCGIAVFAP 639-647
CancerA*02:013358GLIQLVEGVTRAG-3 4-12
CancerA*02:013361ILGVLTSLVDLK1 309-317
CancerA*02:013363LLVPTCVFLV691-700
CancerA*02:013365MLAVFLPIVSTEAP 292-300 (293L)
CancerA*02:013366NLFETPVEA194-202
CancerA*02:013368QLGEQCWTVPSCA 44-51 (51A)
CancerA*02:013371RLAEYQAYISART3 309-317
CancerA*02:013374SIDWFMVTVp31-39
CancerA*02:013375SILLRDAGLVTRAG-3 57-66
CancerA*02:013377SLFEPPPPGPSMA 85-93
CancerA*02:013379SQADALKYVEZH2 729-737
CancerA*02:013386WLSLKTLLSLBcl-2 214-223
CancerA*02:013387YLNRHLHTWIBCL-2 180-189
CancerA*02:013388YLQWIEFSIProminin1 744-752
CancerA*02:013389YLYQWLGAPVOsteocalcin 51-60
CancerA*02:013416KLMSSNSTDLHSP105 234-243
CancerA*02:013417SLYSYFQKVMembrane-associated transporter protein
CancerA*02:013436RLQGISPKISSX2 103-111
CancerA*02:013636AILALLPALLPSCA
CancerA*02:013638ALIHHNTHLHER2 466-474
CancerA*02:013641CMHLLLEAVMG50 624-632
CancerA*02:013643FLIIWQNTMFSP26
CancerA*02:013644FLPWHRLFLLTyrosinase 207-216
CancerA*02:013647FVWLHYYSVTRP2 185-193(L)
CancerA*02:013648GLFGDIYLACSNK1A1 26-34
CancerA*02:013649GLFGDIYLAICSNK1A1 26-35
CancerA*02:013654ILLRDAGLVTRAG-3L 58-66
CancerA*02:013655ILLVVVLGVReceptor tyrosine-protein kinase erbB-2 707-715
CancerA*02:013656ILNAMIAKIHAUS3 154-162
CancerA*02:013658KASEYLQLVMAGEA2 153-161
CancerA*02:013659KIWEELSVLMAGEA3 220-228
CancerA*02:013660KLIDRTE(S)LLSP1 325-333
CancerA*02:013661KLTGDENFTITyrosinase precursor 224-233
CancerA*02:013662LLCYSCKAQVPSCA 17-26
CancerA*02:013666LLLEAVPAVMG50 69-77
CancerA*02:013668LLNQLQVNLMucin2 467-475
CancerA*02:013669LLRDAGLVKMTRAP 59-68
CancerA*02:013670LLRRYNVAKVSOX11 266-275
CancerA*02:013671LLSHGAVIEVAnkyrin NYBR1 158-167
CancerA*02:013673LVFGIELMEVMAGEA3 160-169
CancerA*02:013674LVFGIEVVEVMAGEA12 160-169
CancerA*02:013675MLWGWREHVMucin2 645-653
CancerA*02:013678PLQPEQLQVReceptor tyrosine-protein kinase erbB-2 437-445
CancerA*02:013680QLMAFNHLIPAX3/FKHR 135-143
CancerA*02:013681QLMPYGCLLReceptor tyrosine-protein kinase erbB-2 845-853
CancerA*02:013684RLGPTLMCLMG50 1244-1252
CancerA*02:013687RLTRFLSRVCyclinD 228-236
CancerA*02:013688RTF(S)PTYGLDesmuslin 426-434
CancerA*02:013689SILLRDAGLTRAP 57-65
CancerA*02:013691SLADEAEVYLGAS7 Neoepitope
CancerA*02:013693SLDDYNHLVL-dopachrome tautomerase 288-296
CancerA*02:013695SLYKFSPFPLO-linked N-acetylglucosamine transferase FSP06
CancerA*02:013696SMTR(S)PPRVSFRS2B 241-249
CancerA*02:013698TLEEITGYLReceptor tyrosine-protein kinase erbB-2 448-456
CancerA*02:013699TLHCDCEILMG50 210-218
CancerA*02:013702VLEPPGARDVBIR 7 230-239
CancerA*02:013704VLLALLMAGLProstate stem cell antigen 4-13
CancerA*02:013705VLSVNVPDVMG50 625-633
CancerA*02:013706VLVKSPNHVReceptor tyrosine-protein kinase erbB-4 890-898
CancerA*02:013708VMIG(S)PKKVTensin3 1558-1566
CancerA*02:013709VVLGVVFGIReceptor tyrosine-protein kinase erbB-2 743-751
CancerA*02:013710WLPKILGEVMG50 1051-1059
CancerA*02:013711WLQYFPNPVCytochrome P450 246-254
CancerA*02:013713YLLDLSTNHLFibromodulin 7-15
CancerA*02:013715YLWWVNNQSLCEA 176-185
CancerA*02:013718ALGGHPLLGVDickkopf-related protein 1 20-29
CancerA*02:013719ALLAGLVSLFGFR4 676-684
CancerA*02:013720ALLTYMIAHIThymidylate synthase 231-240
CancerA*02:013721ALMDKSLHVMART-1 56-64
CancerA*02:013722ALPPPLMLLHeparanase 8-16
CancerA*02:013723ALSVMGVYVMAGEA9 223-231
CancerA*02:013724ALVEFEDVLhnRNP L 140-148
CancerA*02:013725ALWPWLLMARNF43 11-19
CancerA*02:013726AMLGTHTMEVMelanocyte-specific secreted glycoprotein 184-193
CancerA*02:013728AVIGALLAVMelanocyte-specific secreted glycoprotein 20-28
CancerA*02:013730CLYGNVEKVhnRNP L 404-412
CancerA*02:013731DLIFGLNALHeparanase 185-193
CancerA*02:013732ELFQDLSQLETV5 54-53
CancerA*02:013733FAWERVRGLCyclin-dependent kinase inhibitor 1 97-105
CancerA*02:013734FIASNGVKLVACTN4 118-127 (K5N)
CancerA*02:013735FLALIICNATubulin beta 4 283-291
CancerA*02:013736FLDEFMEGVMalic enzyme 224-232
CancerA*02:01202ARMFPNAPYLWT-1 126-134 (Wilms tumor)
CancerA*02:01543ALCNTDSPLiLR1
CancerA*02:01550ALKDVEERVMAGE-C2 336-344
CancerA*02:01628LLAARAIVAIiLR1 59-68
CancerA*02:01884RLWQELSDIcircadian clock protein PASD1 691-700
CancerA*02:011303LLFGLALIEVMAGE-C2 191-200
CancerA*02:012194YLNPSVDSVEWS-FLI-1 oncogene
CancerA*02:012282FLDPRPLTVCYP190
CancerA*02:013418STLCQVEPVMPP11
CancerA*02:013419VLQMKEEDViLR1
CancerA*02:013420AIQDLCLAVNPM1
CancerA*02:013421QLLIKAVNLMPP11
CancerA*02:013422AIQDLCVAVNPM1
CancerA*02:013423ALTPVVVTLcyclin-dependent kinase 4 170-178
CancerA*02:01KLLPYIVGVCollagen Type VI Alpha 3 Chain (COL6A3) 414-422
CancerA*02:01SLDDYNHLVTLDopachrome tautomerase (DCT / TRP-2) 288-298
CancerA*02:01LLLDDLLVSIPeroxiredoxin 5 (PRDX5) 110-119
CancerA*02:01SLYKGLLSVDNA repair and recombination protein RAD54B isoform 1 618-626
CancerA*02:01VLLGVKLFGVCollagen type XVIII alpha-1 chain (COL18A1)
CancerA*02:01TLDEKVAELMelanoma-associated antigen C2 (MAGE-C2) 140-148
CancerA*02:01SLMEQIPHLCytoskeleton-Associated Protein 2 (CKAP2)
CancerA*02:01FIADLVVGLAlpha-enolase (ENO1 / 2-phospho-D-glycerate hydro-lyase) 380-388
CancerA*02:01ALWDRVVDLAlkylglycerone phosphate synthase (AGPS) P559L
CancerA*02:01LLMDWVNAVabnormal spindle-like microcephaly-associated (ASPM) 1115-1123
CancerA*02:01KLLEYIEEIHyaluronan-mediated motility receptor (HMMR / RHAMM / CD168) 232-240
CancerA*02:01ALLSGVRQVTyrosine hydroxylase (TH) 174-182
CancerA*02:01QLLALLPSLPreferentially Expressed Antigen in Melanoma (PRAME) 394-402
CancerA*02:01SLSGVMLTDVPreferentially Expressed Antigen in Melanoma (PRAME) 355-364
CancerA*02:01VLWDYVYQLEts variant transcription factor 6 (ETV6)
CancerA*02:01QLLNSVLTLHuman retroelement-silencing factor 1 (RESF1) 248-256
CancerA*02:01AMLVLLAEILatent Nuclear Antigen 1 (LANA-1) 281-289
CancerA*02:01YLYDRLLRVGINS complex subunit 1 (GINS1)
CancerA*02:01HLEEQIAKVNDC80 kinetochore complex component 599-607
CancerA*02:01MLMAQEALAFLCTL-recognized antigen on melanoma (CAMEL) 1-11
CancerA*02:01ALNSEALSVVTMPRSS2:ERG
CancerA*02:01SLADTNSLAVMelanocyte protein PMEL (gp100 or Pmel17) 570-579
CancerA*02:01ALLNIKVKLKeratin, type I cytoskeletal 18 (Keratin-18 or K18) 3650373
CancerA*02:01AMFWSVPTVHuman transketolase isoform 1 (TKT) 425-443
CancerA*02:01VLLRALPVLmutated human mitochondrial ribosomal protein (MRPS17)
CancerA*02:01YISPWILAVX-box binding protein 1 (XBP1) 184-192
CancerA*02:01SLSKILDTVAnkyrin repeat domain-containing protein 30A (ANKRD30A or NY-BR-1) 904-912
CancerA*02:01FLLDGSANVcollagen type VI alpha-3 chain (COL6A3) 642-650
CancerA*02:01MLPEELFELGalectin-3-binding protein (90K / Gal-3BP) 351-359
CancerA*02:01YLHARLRELPreferentially Expressed Antigen in Melanoma (PRAME) 462-470
CancerA*02:01YLSKIIPALReplication factor C subunit 5 (RFC5) 157-165
CancerA*02:01YLSNIIPALreplication factor C subunit 5 (RFC5 K160N) neoantigen 157-165
CancerA*02:01LIYDSSLCDLmammaglobin-A (Mam-A) 83-92
CancerA*02:01SLQEKVAKAHyaluronan-mediated motility receptor (HMMR / RHAMM) 480-488
CancerA*02:01LLDTRTLEVHuman telomerase reverse transcriptase (hTERT / Telomerase) 934-942
CancerA*02:01FLYNLLTRVProtein transport protein Sec24A
CancerA*02:01KLSHQLVLLSorting nexin-24 (SNX24)
CancerA*02:01IMAHCILDLHuman signal recognition particle 9 kDa protein (SRP9) isoform 1
CancerA*02:01RLLDSVSRLLaminin subunit gamma-2 (LAMC2) 850-858
CancerA*02:01LLGKDVLFLPhosphoglycerate kinase 1 (PGK1) 87-95
CancerA*02:01RLQESLKKVPyridoxal-dependent decarboxylase domain-containing protein 1 (PDXDC1) 366-374
CancerA*02:01GLLNSIWPLFamily with sequence similarity 86, member C1 T85I (FAM86C1)
CancerA*02:01YLYDRLLRIGINS triad/tetad complex subunit 1 (PSF1 / GINS1) 79-87
CancerA*02:01FLIYLDVSVWD Repeat Domain 46 (WDR46) T300I
CancerA*02:01FLYNPLTRVProtein transport protein Sec24A 450-458
CancerA*02:01TIDDGIFEVHeat shock 70 kDa protein 1A (HSPA1A / HSP70-1) 213-221
CancerA*02:01ALGALTVWLzinc finger DHHC-type containing 16 (ZDHHC16)
CancerA*02:01FLSDHLYLVCDC37 family co-chaperone-like protein 1 (CDC37L1) P183L
CancerA*02:01ILTGLNYEVNAD(P) dependent steroid dehydrogenase-like (NSDHL) A290V
CancerA*02:01FLAMLKNTVCancer/testis antigen 7 (CT7 / MAGE-C1) 1087-1095
CancerA*02:01SLDGKAIKVRNA-binding motif protein, X-linked (RBMX) 73-81
CancerA*02:01LLWGHPRVALAmatrix-remodeling associated 5 (MXRA5) 16-26
CancerA*02:01ALDGGNKHFLpremature melanoma-associated gp100 (PMEL) 224-233
CancerA*02:01LLDGTATLRLMelanocyte protein PMEL (gp100 / Pmel17) 457-466
CancerA*02:01SLTALVFHVNon-coding 3' untranslated region (3' UTR) translated via alternative or cryptic reading frames
CancerA*02:01RLDAVLMEVMyosin regulatory light chain interacting protein (MYLIP or IDOL)
CancerA*02:01FLLDSCTKLCCT4.S115F (a mutated variant of the chaperonin containing TCP1 subunit 4 protein)
CancerA*02:01HIAKSLFEVFilamin-A (FLNA) 364-372
CancerA*02:01LLLGIGILVBone marrow stromal cell antigen 2 / Tetherin (HM1.24 / BST2) 22-30
CancerA*02:01FLGPWPAAVLow-density lipoprotein receptor-related protein-associated protein 1 (LRPAP1 or RAP)
CancerA*02:01AMLERQFTVProtein N-lysine methyltransferase (METTL21A) 185-193
CancerA*02:01KLFPGSPAIRAN GTPase activating protein 3 domain containing 8 (RGPD8 ) 122-131
CancerA*02:01FLMIHLQRVRAC GTPase-activating protein 1 (RACGAP1) 475-483
CancerA*02:01MLGERLFPLPolyadenylate-binding protein 1 (PABPC1) 556-564
CancerA*02:01MLIGIPVYVring finger protein 19B (RNF19B) V372L
CancerA*02:01ELFPQLISVX-box binding protein 1 (XBP1) 368-376
CancerA*02:01ALSDETWGLGrowth factor receptor-bound protein 7 (GRB7) 137-145
CancerA*02:01KLVVVGAAGVKRAS proto-oncogene, GTPase (K-Ras) G12A
CancerA*02:01GLAPPQHLICellular tumor antigen p53 (TP53) 187-195
CancerA*02:01HLYASLSRVHuman mitochondrial ribosomal protein S5 (MRPS5 isoform CRA_b / MRPS5 mutated variant
CancerA*02:01KVFAGIPTVReceptor-type tyrosine--protein phosphatase zeta (PTPRZ1) 1333-1341
CancerA*02:01CLNEYHLFLtransmembrane protein 48 (TMEM48) 161-169
CancerA*02:01ALREEEEGVMelanoma-Associated Antigen 1 (MAGE-A1) 301-309
CancerA*02:01FLLDEAIGLSpeckle-type POZ protein (SPOP)
CancerA*02:01AMIPKDWPLHuman endogenous retrovirus group K member 113 (HERV-K113) Pol protein 113 - 120
CancerA*02:01YLDPAQRGVMethyltransferase-like protein 26 (METTL26) 21-29
CancerA*02:01LLHGFSFYLProtein-serine O-palmitoleoyltransferase porcupine (PORCN) 339–347
CancerA*02:01YLYHRVDVIUbiquitin-Specific Peptidase 7 (USP7) D798Y
CancerA*02:01QLSRELLPVlipoxygenase homology domain-containing protein 1 (LOXHD1) 1134-1142
CancerA*02:01RLIPYDWEIGag polyprotein 344-352
CancerA*02:01RLFPDFFTRVProteinase 3 (PR3) 227-236
CancerA*02:01FLPEFGISSAlens protein with a glutamine synthetase-like domain (Lengsin) 270-279
CancerA*02:01YLVYQMLKVMitogen-activated protein kinase 13 (MAPK13) G137V
CancerA*02:01FLTYLDVSVWD repeat domain 46 (WDR46) 298-306
CancerA*02:01KMILKMVQLPreferentially Expressed Antigen in Melanoma (PRAME) 224-232
CancerA*02:01TLAKFSPYLPreferentially Expressed Antigen in Melanoma (PRAME) 248-256
CancerA*02:01AIISGDSPVMyeloid cell surface antigen CD33 (Siglec-3) 65-73
CancerA*02:01KMIGNHLWVCyclin-dependent kinase inhibitor 2A (CDKN2A)
CancerA*02:01TVIGELTSVTubulin alpha-1A chain 73-81
CancerA*02:01SAMTNLAALProstatic acid phosphatase 115-123
CancerA*02:01YIGEVLVSMClass I myosin heavy chain
CancerA*02:01AIDAALTFVNuclear pore membrane glycoprotein 210 (NUP210)
CancerA*02:01ALIHHNTYLErb-B2 Receptor Tyrosine Kinase 2 (ERBB2 or HER2) H473Y
CancerA*02:01KLIDCYTFLHuman endogenous retrovirus K (HERV-K provirus / HERV-K) 208-216
CancerA*02:01GLDDMKANLPaired box protein Pax-5 (PAX5) 273-281
CancerA*02:01YMFPNAPYLWilms' tumor 1 (WT1) 199-207
CancerA*02:01KILEKEIRVhyaluronan-mediated motility receptor (HMMR) 85-93
CancerA*02:01TIDDIVLTICation channel sperm-associated protein 4 (CATSPER4)
CancerA*02:01VLQNVAFSVBcl-2-related protein A1 (BCL2A1) 36-44
CancerA*02:01MLAVISCAVtumor-associated T cell epitope derived from the envelope protein of the HERV-K-MEL human endogenous retrovirus
CancerA*02:01FLDLPEPLLDEP domain-containing protein 1 (DEPDC1) 283-291
CancerA*02:01FLRNFSLMVT-cell receptor gamma alternate reading frame protein (TARP) 27-35
CancerA*02:01TLWCSPIKVSushi repeat-containing protein X-linked (SRPX)
CancerA*02:01FLRNFSLMLT-cell receptor gamma alternate reading frame protein (TARP) 27-35
CancerA*02:01FMFQEALKLMelanoma-associated antigen 9 (MAGE-A9) 102-110
CancerA*02:01FLCMKALLLAndrogen Receptor (AR) 805-813
CancerA*02:01KLSHQPVLLSorting Nexin-24 (SNX24) protein 127-135
CancerA*02:01SMPDFDLHLNeuroblast differentiation-associated protein AHNAK 2580–2588
CancerA*02:01HVDGFIANVreceptor tyrosine-protein kinase erbB-3 (HER3 / ErbB-3) 113-121
CancerA*02:01KLVVVGAGDVKRAS G13D
CancerA*02:01EVIGPDGLITVRopporin-1B (ROPN1B) 190-200
CancerA*02:01LIMQLMPFGCLEpidermal Growth Factor Receptor (EGFR) T790M 100-110
CancerA*02:01NLSSAEVVVInsulin-like growth factor II mRNA-binding protein 3 (IMP3) 515-523
CancerA*02:01RLFFYRKSVHuman telomerase reverse transcriptase (hTERT) 572-580
CancerA*02:01KLMNIQQQLA-kinase anchor protein 13 (AKAP13) 278-286
CancerA*02:01FMPDFDLHLneuroblast differentiation-associated protein AHNAK
CancerA*02:01IMQLMPFGCLLEpidermal Growth Factor Receptor (EGFR) 101-111
CancerA*02:01VVVPYEPPEVTumor suppressor p53 216-225
CancerA*02:01VVVPCEPPEVTumor suppressor p53 Y220C 216-225
CancerA*02:01YLSFIKILLHuman Endogenous Retrovirus group K (HERV-K) 15-23
CancerA*02:01YAMSNLFSIHuman Endogenous Retrovirus group K (HERV-K) 287-295
CancerA*02:01FMFVNSLLLWD repeat-containing protein 75 (WDR75)
CancerA*02:01QLCDVMFYLBRCA1-associated protein (BRAP)
CancerA*02:01ILTGLNYEANAD(P)-dependent dehydrogenase/isomerase-like (NSDHL) 282-290
CancerA*02:01FLVREDFVLCathepsin G 52-60
CancerA*02:01SLGDWGAEAMetalloproteinase inhibitor 3 (TIMP3) 15-23
CancerA*02:01FLWGPRALAMelanoma-associated antigen A4 (MAGE-A4) 272-280
CancerA*02:01FLQFKTWWIHuman endogenous retrovirus K (HERV-K) 363-371
CancerA*02:01LLLPLLPPLSPInsulin-like growth factor-binding protein-like 1 (IGFBPL1) 14-24
CancerA*02:01SLFEGIDIYTHeat shock protein 70 family (Hsp70-2 / HSPA1A) F293I
CancerA*02:01KLVEFDFLGATransforming acidic coiled-coil-containing protein 3 (TACC3) 599-608
CancerA*02:01ALLPSLSHCPreferentially Expressed Antigen in Melanoma (PRAME) 397-405
CancerA*02:01FVYGEPRELMelanoma-associated antigen C2 (MAGE-C2) 265-273
CancerA*02:01MVIGIPVYVRNF19B protein 180-188
CancerA*02:01YVYQNEHEVAldo-keto reductase family 1 member B10 (AKR1B10) 47-55
CancerA*02:01QLSCISTYVOlfactory receptor 8B3 (OR8B3)
CancerA*02:01GTLEEVPTAMelanoma-associated antigen 1 (MAGE-A1) 41-49
CancerA*02:01FLDRFLSCMCyclin-A1 227-235
CancerA*02:01CLLWSFQTSAtyrosinase 8-17
CancerA*02:01YLNSGIHSGABeta-catenin D32N
CancerA*02:01AVIDAYTEILa-related protein 7 isoform 2 LARP7)
CancerA*02:01QMFFCFKELSurvivin (Baculoviral IAP repeat-containing protein 5 / BIRC5)
CancerA*02:01GTIGIFWFVSialin isoform 6 (SLC17A5) 234-242
CancerA*02:01FLDETLRSLAGDNF family receptor alpha-2 (GFRA2) 12-21
CancerA*02:01FVFLRNFSLT-cell receptor gamma alternate reading frame protein (TARP) 27-35
CancerA*02:01VVAAHLAGACartilage intermediate layer protein 2 (12-20)
CancerA*02:01RVLHSPPAVMicrotubule Actin Crosslinking Factor 1 (MACF1) 1510-1518
CancerA*02:01GVYAGREHFVMelanoma-associated antigen C2 (MAGE-C2) 257-266
CancerA*02:01IMNDMPIYMEphrin type-A receptor 2 (EphA2) 58-66
CancerA*02:01KLLEIAPNCtruncated large T antigen 15-23
CancerA*02:01FVGALSFSINPC intracellular cholesterol transporter 1
CancerA*02:01ACDPHSGHFVCyclin-dependent kinase 4 (CDK4) R24C
CancerA*02:01AMPFATPMEANY-ESO-1 93-102
CancerA*02:01KQIDQFLVVMetastasis-associated protein 1 (MTA1) 122-130
CancerA*02:01AMPFSIFYPMOtopetrin-1 (OTOP1)
CancerA*03:0187KQSSKALQRbcr-abl 210 kD fusion protein 21-29
CancerA*03:01118ALLAVGATKgp100 (pmel17) 17-25
CancerA*03:01264ATGFKQSSKbcr-abl 210 kD fusion protein 259-269
CancerA*03:01541RISTFKNWPKSurvivin-3A 18-27 (27K)
CancerA*03:01552RLGLQVRKNKRhoC 176-185 (177L)
CancerA*03:01615RLLFFAPTRMcl-1 95-103
CancerA*03:013369QVLKKIAQKHMOX1 145-153
CancerA*03:013370RIAAWMATY165-173
CancerA*03:01KLYSEAKTKCytotoxic and regulatory T-cell molecule 363-371
CancerA*03:01RVSLPKLGYKCD59 48-57
CancerA*03:01RLNAALREKReceptor for Hyaluronan-Mediated Motility (HMMR) 118-126
CancerA*03:01RLWKPQEPK
CancerA*03:01RTAGHPLTRTyrosine-protein phosphatase non-receptor type 7 (76-84)
CancerA*03:01LIYRRRLMKpremelanosome protein (Melanocyte protein PMEL) 614-622
CancerA*03:01STYPAQNGQVKReceptor-type tyrosine-protein phosphatase C (PTPRC / CD45) 1227-1237
CancerA*03:01RLVELAGQSLLKPreferentially Expressed Antigen in Melanoma (PRAME) 25-36
CancerA*03:01SLHAYIIAKProtein Tyrosine Phosphatase Receptor Type C / CD45 (PTPRC) 266-274
CancerA*03:01ALNFPGSQKMelanocyte protein PMEL (gp100) 87-95
CancerA*03:01ALHGGWTTKPhosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha H1047L
CancerA*03:01VLRENTSPKErbB-2 receptor tyrosine-protein kinase (HER-2/neu or ERBB-2) 754-762
CancerA*03:01HLFGYSWYKCarcinoembryonic antigen (CEA / CEACAM5) 61-69
CancerA*03:01AVASVPIMYEZH2 (Enhancer of zeste homolog 2) 103-111
CancerA*03:01SVMGVYVGKMelanoma-associated antigen A9 (MAGE-A9) 225-233
CancerA*03:01TVYHSPVSRProtein Regulator of Cytokinesis 1 (PRC1) 509-517
CancerA*03:01TSALPIIQKPerilipin-2 (PLIN2) 63-71
CancerA*03:01AAFKRSCLKlarge T antigen [Merkel cell polyomavirus] 32-40
CancerA*11:01785VVGAVGVGKKRAS G12V (8-16)
CancerA*11:013070VVVGADGVGKKRAS G12D (7-16)
CancerA*11:013072VVVGAVGVGKKRAS G12V (7-16)
CancerA*11:01RVWDLPGVLKcentromere protein M isoform c (3-12)
CancerA*11:01HTMGFWLTKvon Hippel-Lindau tumor suppressor 23-31
CancerA*11:01VVVGARGVGKKras oncogene protein G12R 7-16
CancerA*11:01VVGAGGVGKKras oncogene protein 8-16
CancerA*11:01VVGARGVGKKras oncogene protein G12R 8-16
CancerA*11:01SSYTGFANKKinesin Family Member 26B (KIF26B) 254-263
CancerA*11:01ASNAPSAAKprobable E3 ubiquitin-protein ligase (HERC1) 3274-3282
CancerA*11:01SVLKPGNSKE74-like factor 1 (ELF1)
CancerA*11:01ASNASSAAKProbable E3 ubiquitin-protein ligase (HERC1) S3278S
CancerA*11:01SVSKLSTPKZinc finger and BTB domain-containing protein 1 (ZBTB1) 197-205
CancerA*11:01RSGGFSFGKlarge T antigen, partial [Merkel cell polyomavirus] 95-103
CancerA*11:01TVLKPGNSKE74-like factor 1 (ELF1) 319-327
CancerA*11:01AIKTSPKANKEpidermal Growth Factor Receptor (EGFR)
CancerA*11:01ALIVFWKYRKita-kyushu lung cancer antigen 1 (KK-LC-1) 14-22
CancerA*11:01ALNFPGSQKMelanocyte protein PMEL 87-95
CancerA*24:02209TYACFVSNLCarcinogenic Embryonic Antigen (CEA) 652-660
CancerA*24:02230AFLPWHRLFTyrosinase 188-196
CancerA*24:02237IMPKAGLLIMAGE-A3
CancerA*24:02238VYFFLPDHLgp100-intron 4 (170-178)
CancerA*24:02416EYLQLVFGIMAGEA2 156-164
CancerA*24:02417TYLPTNASLHER-2/neu 63-71
CancerA*24:02418VYGFVRACLTelomerase reverse transcriptase (hTRT) 461-469
CancerA*24:02421TFPDLESEFMAGEA3 97-105
CancerA*24:021064DYLQYVLQIMiHA ACC1 15-23
CancerA*24:021806RYCNLEGPPILymphocyte antigen 6 complex locus K (LY6K) 177-186
CancerA*24:022302AYACNTSTLSurvivin 80-88
CancerA*24:022303CYASGWGSIProstate Specific Antigen-1 153-161
CancerA*24:023351DYLNEWGSRFCDH3 807-816
CancerA*24:023353EYCPGGNLFMELK 87-95 (93N)
CancerA*24:023354EYYELFVNIDEP DC1 294-302
CancerA*24:023360GYCTQIGIFHENMT1 221-229
CancerA*24:023362IYTWIEDHFFOXM1 262-270
CancerA*24:023367NYQPVWLCLRNF43 721-729 (722Y)
CancerA*24:023372RYNAQCQETIMidkine 110-119
CancerA*24:023380EYRALQLHLCA9 219-227
CancerA*24:023382SYRNEIAYLTTK protein kinase 551-559
CancerA*24:023384VYLRVRPLLKIF20A 67-75
CancerA*24:023385VYYNWQYLLIL13r 146-154
CancerA*24:02SYQKVIELFT-lymphokine-activated killer cell-originated protein kinase (TOPK) 289-297
CancerA*24:02LYPEFIASIDPY19-like protein 4 (DPY19L4) L143F
CancerA*24:02IYLDLPWYLToll-like receptor 1 (TLR1) S602I
CancerA*24:02IYPDITYSLCholinergic Receptor Nicotinic Alpha 3 (CHRNA3) 227-235
CancerA*24:02IYPQVLHSLE3 ubiquitin-protein ligase RNF213 (Ring finger protein 213) 3834-3842
CancerA*24:02TYSPALNKMFCellular tumor antigen p53 125-134
CancerA*24:02RYYVGHKGKFProtein mago-nashi homolog 2 / B (MAGOHB) 10-19
CancerA*24:02RYYVGHKAKFProtein mago-nashi homolog 2 / B (MAGOHB) G17A 10-19
CancerA*24:02DYGMIDESIcancer/testis antigen CT55 49-57
CancerA*24:02QYSPVQATFcoenzyme A synthase (COASY S55Y)
CancerA*24:02LYAPYSTHFG protein-coupled receptor class C group 5 member A (GPRC5A) 316-324
CancerA*24:02PYVSRLLGIReceptor tyrosine-protein kinase erbB-2 (HER2/neu) 780-788
CancerA*24:02SYNPLWLRIabnormal spindle-like microcephaly-associated (ASPM) 818-826
CancerA*24:02KWLISPVKIHolliday junction recognition protein (HJURP) 408-416
CancerA*24:02LYAPTILLWAlpha-fetoprotein (AFP) 173-181
CancerA*24:02MWITQCFLPVFCancer/testis antigen 1 (NY-ESO-1) 160-170
CancerA*29:023397KEKYIDQEELHSP90 alpha 280-288 (Pathologic Conditions)
CancerA*68:013398TVSGNILTIRNY-ESO-1 127-136
CancerB*07:022304LPWHRLFLLTyrosinase 208-216
CancerB*07:022369EPR(PHOSPHO-S)PSHSMKMT2A / pMLL 747-755
CancerB*07:023239TPNQRQNVCP2X5
CancerB*07:023348APRGVRMAVLAGE-1 46-54
CancerB*07:023364LPVSPRLQLCEACAM 185-193
CancerB*07:02PPSGLRLLPLTransforming growth factor beta-1 proprotein (TGF-β1) 2-11
CancerB*07:02RPRLGNRPSLlymphoblastoid cell line (GR-LCL)
CancerB*07:02APLPRPGAVLCancer/Testis Antigen 2 / LAGE-1 (CTAG2) 114-123
CancerB*07:02KPRPDVTNELCell division cycle-associated protein 7 (CDCA7) 94-103
CancerB*07:02RPPPPPAWLLysine-specific demethylase 6B (KDM6B) 478-486
CancerB*07:02APNCYGNIPLT-antigen (LTA) of the Merkel cell polyomavirus 20-29
CancerB*07:02GPRMQLCTQLRING finger protein 43 (RNF43)
CancerB*07:02SPVTEIRTDLPartner and localizer of BRCA2 (PALB2)
CancerB*07:02KPSDTPRPVMMixed-Lineage Leukemia protein 3 / Histone-lysine N-methyltransferase (MLL3 or KMT2C)
CancerB*07:02FPSLREAALMelanoma-associated antigen 1 (MAGE-A1) 294-302
CancerB*07:02MPMQDIKMILPreferentially Expressed Antigen in Melanoma (PRAME) 218-227
CancerB*07:02IPQQHTQVLCarcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) 632-640
CancerB*07:02NPRYPNYMFTyrosine-protein kinase transmembrane receptor (ROR1) 783-791
CancerB*07:02RPILTIITLCellular tumor antigen p53 210-218
CancerB*07:02KPFCVLISLDOPEY2
CancerB*07:02RPHHDQRSLHuman tau-tubulin kinase 2 (TTBK2) S1181L
CancerB*07:02GADGVGKSALKRAS G12D
CancerB*07:02RVRFFFPSLMelanoma-associated antigen 1 (MAGE-A1) 289-297
CancerB*07:02RVAGSMSSLRoundabout homolog 3 (ROBO3)
CancerB*08:0194GFKQSSKALbcr-abl 210 kD fusion protein 19-27
CancerB*08:01ESKIRVLLHyaluronan-mediated motility receptor (HMMR) 73-80
CancerB*08:01APLLRWVLHeme oxygenase 1 (HMOX1 / HO-1) 265-272
CancerB*27:05424GRFGLATEKBRAF 594-601 (600E)
CancerB*27:053359GRFGLATVKBRAF 594-601 (600V)
CancerB*27:05202BRMFPNAPYLWT-1 126-134 (Wilms tumor)
CancerB*27:05RREDVVLGRT-cell leukemia/lymphoma protein 1A (TCL1A) 52-60
CancerB*35:012307MPFATPMEANY-ESO-1 94-102
CancerB*35:01MPFATPMEAELcancer-testis antigen NY-ESO-1 (LAGE-2) 94-104
CancerB*35:01FSFGKAYEYLarge T antigen 99-107
CancerH-2Db1731ATFKNWPFLMurine Survivin 20-28
CancerH-2Db2415YSSDNLYQMWilms Tumor protein (221- 229)
CancerH-2Db231CMTWNQMNLWT1 235-243
CancerH-2Db559HCIRNKSVIPSA 65-73
CancerH-2Db695Abu-Abu-L-Abu-LTVFLMoloney murine sarcoma virus (MoMSV) GagL 85-93
CancerH-2Db1333KVPRNQDWLgp100 (pmel17) 25-33
CancerH-2Db1780HCIRNKSVILhPSA
CancerH-2Db2198VILTNPISMVEGFR2 400-408
CancerH-2Db2199FSNSTNDILIVEGFR2/KDR fragment 1 614-624
CancerH-2Db2675STHVNHLHCEndophilin-B2 244-252
CancerH-2Db2695ASMTNMELMMC-38 Adpgk neoantigen
CancerH-2Db2755AQLANDVVLMC-38
CancerH-2Db3349ASFRNLTHLTPBG 258-266
CancerH-2Db202CRMFPNAPYLWT-1 126-134 (Wilms tumor)
CancerH-2DbNAVGNPEYLEpidermal growth factor receptor (EGFR) 1131-1139
CancerH-2DbASMTNRELMADP-dependent glucokinase isoform 1 precursor 299-307
CancerH-2DbAALLNSAVLImmunity-related GTPase family Q protein-like (Irgq)
CancerH-2DbSSMHNALHITyrosinase 360–368
CancerH-2DbAQLPNDVVLRalBP1-associated Eps domain-containing protein 1 (Reps1) 42-50
CancerH-2DbYGFRNVVHIHeat shock factor 2 (Hsf2) 68-76
CancerH-2DbSSISNFQAVInterferon-inducible/activated gene family (Ifi203a) 260-268
CancerH-2DbTQNVNQAKMmelanoma-associated antigen D1 (MAGE-D1) 196-204
CancerH-2DbSSPYSLHYLCopine-1 (Cpne1)
CancerH-2DbMAPIDHTTMapoptosis-antagonizing transcription factor AATF 493-501
CancerH-2DbIGISNYPESTI53BP1 protein 924-934
CancerH-2DbSAIRSYQYVSpire1
CancerH-2DdTGAARFDEFGeneral transcription factor IIB
CancerH-2Kb351HNTQYCNLMAGEA5 5-12
CancerH-2Kb2311TVSEFLKLMurine Survivin 97-104
CancerH-2Kb185SVYDFFVWLTyrosinase related protein-2 180-188
CancerH-2Kb2585VGRNFTNLmTERT
CancerH-2Kb2754SIIVFNLLMC-38
CancerH-2Kb3373SDYYFSWLmuFAP 289-296
CancerH-2Kb3376SKYVFENVMybpc2 295-302
CancerH-2KbLGYDYSYLmouse tyrosinase 445–452
CancerH-2KbHIYEFPQLProtein unc-119 homolog B 203-210
CancerH-2KbRSYRYKLLMetalloreductase STEAP1 186-193
CancerH-2KbKMYQYARLRIO kinase 1 (RIOK1) G946T
CancerH-2KbQVYRFLGVthyroglobulin precursor 2223-2230
CancerH-2KbATLVFHNLSignal transducer and activator of transcription 3 (STAT3) 53-60
CancerH-2KbATQQFQQLgPr80 glycosylated envelope polyprotein 500-508
CancerH-2KbKILTFDRL60S ribosomal protein L18 (Rpl18) 119-126
CancerH-2KbSNPTYSVMPolyomavirus middle-T (PyMT) antigen 246-253
CancerH-2KbSIIVFNLVGlcNAc-1-P transferase 206-213
CancerH-2KbAPNCYGNIMerkel cell polyomavirus (MCPyV) large T antigen 20-27
CancerH-2KdSYGVTVWELReceptor tyrosine-protein kinase erbB-2 (HER2/neu) 907-915
CancerH-2KdSYMAPSTVLUbiquinol-cytochrome c reductase core protein II (UQCRC2)
CancerH-2KdKYSEVFEAICasein kinase II subunit alpha (Csnk2a1) 50-58
CancerH-2KdSFYDVKGDLGuanylate cyclase 2c (GUCY2C) 254-262
CancerH-2KdKFKASRASINeoantigen CT26 mouse colon tumor cell line model
CancerH-2Kd343TYVPANASLNeu/Her-2/Erbb2 proto-oncoprotein 66-74
CancerH-2Kd485AYIDFEMKISART3 315-323
CancerH-2Kd814EYILSLEELGPC3 298-306
CancerH-2Kd3381SYMLQALCITNPO3
CancerH-2Ld150LPYLGWLVFTumour Antigen P815 35-43
ChagasA*02:01TLEEFSAKLKinetoplastid Membrane Protein-11 (KMP-11) 4-12
ChagasA*02:01RLYKTLGQLMajor paraflagellar rod protein 2 (PFR2) 449-457
ChagasA*02:01ALRNLRVFLSurface Antigen 2 (TcCA-2) 607-615
ChagasA*02:01FVSCCGELTVTrypanosoma cruzi Paraflagellar rod component 3 (putative PFR3) 428–436
ChagasA*02:01TVFDASRSTVTrypanosoma cruzi surface antigen TcCA-2 (Surface antigen 2) 1077-1086
ChlamydiaA*02:01334RLNMFTPYIChlamydia trachomatis MOMP 258-266
ChlamydiaA*02:01335NMFTPYIGVMOMP precursor 283-291
ChlamydiaB*27:053094ARKLLLDNLPqqC-like protein 70-78
ChlamydiaB*27:053945NRAKQVIKLProbable ATP-dependent Clp protease ATP-binding subunit 7-15
ChlamydiaB*27:05KRLAETLALCT589 67-75
ChlamydiaH-2Db3943ASFVNPIYLCysteine-rich membrane protein 63-71
ChlamydiaH-2Db3947SAVSNLFYVPOMP 612-620
CMVA*01:01266YSEHPTFTSQYHCMV pp65 363-373
CMVA*01:01739VTEHDTLLYHCMV pp50 245-253
CMVA*02:018NLVPMVATVHCMV pp65 495-504
CMVA*02:01144VLEETSVMLHCMV IE1 316-324 (UL123)
CMVA*02:011598VLAELVKQIHCMV IE1 81-89
CMVA*02:012205MLNIPSINVpp65 120-128
CMVA*02:01NLVPPVATVLower matrix phosphoprotein pp65 (UL83) 495-503
CMVA*02:01NLVGMVATVPhosphoprotein 65 (pp65 / UL83) 495-503
CMVA*02:01NLVPMVGTVLower matrix phosphoprotein pp65 495-503
CMVA*02:01QMWQARLTVPhosphoprotein 65 (pp65 / UL83) 155-163
CMVA*02:01YILEETSVMImmediate-early protein 1 (IE-1) 315-323
CMVA*03:011599KLGGALQAKHCMV IE1 184-192
CMVA*24:02380VYALPLKMLHCMV pp65 113-121
CMVA*24:02414QYDPVAALFHCMV pp65 341-349
CMVA*24:023390AYAQKIFKICMV IE-1 248-256
CMVA*24:02AYAQKIFKILImmediate-early protein 1 (IE1) 248-257
CMVB*07:0245TPRVTGGGAMHCMV pp65 417-426
CMVB*07:02308RPHERNGFTVLHCMV pp65 265-275
CMVB*08:01127ELRRKMMYMIE1 199-207
CMVB*08:013391ELKRKMIYMCMV IE-1 199-207 (R/L Position 3, M/I Position 7)
CMVB*08:01SPRSRLQQLImmediate-early protein 2 (IE2) 1151-1159
CMVB*08:01ELNRKMIYMImmediate-early protein 1 (IE-1) 51-59
CMVB*35:01114IPSINVHHYHCMV pp65 123-131
CMVC*06:023264TRATKMQVIpp65 211-219
CMVC*06:023744QIKVRVDMIE1 88-95
CMVC*07:023269CRVLCCYVLIE1 309-317
CMVH-2Db2313HGIRNASFIMCMV m45 985-993
CMVH-2Dd278AGPPRYSRIMCMV m164 257-265
CMVH-2Dd2167LGPISGHVLpp65 15-23
CMVH-2Kb1915TVYGFCLLMCMV M139 419-426
CMVH-2Kd3412CYYASRTKLMCMV m145 451-459
CMVH-2Ld21YPHFMPTNLMCMV IE1 168-176
COVID-19 / SARS-CoV-2A*01:014355FTSDYYQLYSARS-CoV-2 ORF3a 207-215 (confirmed epitope)
COVID-19 / SARS-CoV-2A*01:014381TTDPSFLGRYSARS-CoV-2 Replicase polyprotein 1ab 1637-1646 (confirmed epitope)
COVID-19 / SARS-CoV-2A*01:014382PTDNYITTYSARS-CoV-2 Replicase polyprotein 1ab 1621-1629 (confirmed epitope)
COVID-19 / SARS-CoV-2A*01:014501CTDDNALAYYSARS-Cov-2 ORF1ab 4163-4172
COVID-19 / SARS-CoV-2A*01:014690HTTDPSFLGRYSARS-CoV-2 ORF1ab 1641-1651
COVID-19 / SARS-CoV-2A*01:014726IVDTVSALVYSARS-CoV-2 ORF1ab 5781-5789
COVID-19 / SARS-CoV-2A*01:01CTDDNALAYReplicase polyprotein 1ab 4163-4172
COVID-19 / SARS-CoV-2A*01:01GTDLEGNFYReplicase polyprotein 1ab 3437-3445
COVID-19 / SARS-CoV-2A*01:01VTPSGTWLTYnucleocapsid phosphoprotein 324-333
COVID-19 / SARS-CoV-2A*01:01DTDFVNEFYReplicase polyprotein 1ab 5130-5138
COVID-19 / SARS-CoV-2A*01:01WTAGAAAYYsurface glycoprotein 258-266
COVID-19 / SARS-CoV-2A*02:014320LLLDRLNQLSARS-CoV Nucleocapsid protein 223-231 (conserved in SARS-CoV-2)
COVID-19 / SARS-CoV-2A*02:014321FIAGLIAIVSARS-CoV-2 Spike glycoprotein 1220-1228 (confirmed epitope)
COVID-19 / SARS-CoV-2A*02:014322ALNTLVKQLSARS-CoV Spike glycoprotein precursor 940-948 (conserved in SARS-CoV-2)
COVID-19 / SARS-CoV-2A*02:014323LITGRLQSLSARS-CoV-2 Spike glycoprotein 996-1004 (confirmed epitope)
COVID-19 / SARS-CoV-2A*02:014324NLNESLIDLSARS-CoV
Spike glycoprotein precursor 1174-1182 (conserved in SARS-Cov-2)
COVID-19 / SARS-CoV-2A*02:014326VLNDILSRLSARS-CoV Spike glycoprotein precursor 958-966 (conserved in SARS-Cov-2)
COVID-19 / SARS-CoV-2A*02:014339YLQPRTFLLSARS-Cov-2 Spike glycoprotein 269-277 (confirmed epitope)
COVID-19 / SARS-CoV-2A*02:014342LLYDANYFLSARS-CoV-2 ORF3a 139-147 (confirmed epitope)
COVID-19 / SARS-CoV-2A*02:014358RLQSLQTYVSARS-CoV-2 Spike glycoprotein 1000-1008 (confirmed subdominant epitope)
COVID-19 / SARS-CoV-2A*02:014418KLWAQCVQLSARS-CoV-2 ORF1ab 3886-3894 (confirmed epitope)
COVID-19 / SARS-CoV-2A*02:014725TLVPQEHYVSARS-CoV-2 ORF1ab 5563-5571
COVID-19 / SARS-CoV-2A*02:014340KIADYNYKLSARS-CoV-2 Spike glycoprotein 417-425
COVID-19 / SARS-CoV-2A*02:01LLLLDRLNQLNucleoprotein 221-230
COVID-19 / SARS-CoV-2A*02:01KLSYGIATVReplicase polyprotein 1ab (pp1ab) / ORF1ab 5470-5478
COVID-19 / SARS-CoV-2A*02:01ALSKGVHFVOpen Reading Frame 3a (ORF3a) 72–80
COVID-19 / SARS-CoV-2A*02:01SMWALVISVReplicase polyprotein 1ab / pp1a 3661-3669
COVID-19 / SARS-CoV-2A*02:01YLNTLTLAVnon-structural protein 16 (NSP16) 53-61
COVID-19 / SARS-CoV-2A*02:01VLAWLYAAVReplicase polyprotein 1ab (ORF1ab non-structural region) 3467-3475
COVID-19 / SARS-CoV-2A*02:01KLLEQWNLVMembrane (M) structural glycoprotein 15–23
COVID-19 / SARS-CoV-2A*02:01FLNGSCGSVReplicase polyprotein 1ab (ORF1ab / pp1ab) 3403–3411
COVID-19 / SARS-CoV-2A*02:01GLMWLSYFVmembrane (M) protein 89-97
COVID-19 / SARS-CoV-2A*02:01RLANECAQVRNA-dependent RNA polymerase (RdRp) ORF1ab 5046-5054
COVID-19 / SARS-CoV-2A*02:01VLWAHGFELORF1ab polyprotein / Non-structural protein 14 (nsp14-ExoN) 6109-6117
COVID-19 / SARS-CoV-2A*02:01HLVDFQVTIAccessory protein ORF6 3–11
COVID-19 / SARS-CoV-2A*02:01ILFTRFFYVReplicase polyprotein 1ab / pp1a (ORF1ab region) 2332-2340
COVID-19 / SARS-CoV-2A*02:01SLVKPSFYVEnvelope (E) protein 50-58
COVID-19 / SARS-CoV-2A*02:01ALYYPSARIReplicase polyprotein ORF1ab 5620-5628
COVID-19 / SARS-CoV-2A*02:01GLALYYPSAReplicase polyprotein 1ab 5618-5626
COVID-19 / SARS-CoV-2A*02:01KIYSKHTPISpike (S) glycoprotein 202-210
COVID-19 / SARS-CoV-2A*02:01SMWSFNPETMembrane (M) structural 108-116
COVID-19 / SARS-CoV-2A*02:01RTIKVFTTVORF1ab 1566-1574
COVID-19 / SARS-CoV-2A*02:01YTVSCLPFTORF8 protein 79-87
COVID-19 / SARS-CoV-2A*03:014443KCYGVSPTKSARS-CoV-2 Spike glycoprotein 378-386
COVID-19 / SARS-CoV-2A*03:014724KLFAAETLKSARS-CoV-2 ORF1ab 5455-5463
COVID-19 / SARS-CoV-2A*03:014356AKTFPPTEPKSARS-CoV-2 Nucleocapsid protein 362-370 (confirmed epitope)
COVID-19 / SARS-CoV-2A*03:014691AVTNNTFTLKSARS-CoV-2 ORF1ab 808-816
COVID-19 / SARS-CoV-2A*03:014679ASVYAWNRKRSARS-CoV-2 Spike glycoprotein 349-357
COVID-19 / SARS-CoV-2A*03:01KTIQPRVEKReplicase polyprotein 1a 282-290
COVID-19 / SARS-CoV-2A*03:01VVYRGTTTYKReplicase polyprotein 1ab 5533-5542
COVID-19 / SARS-CoV-2A*03:01RIAGHHLGRMembrane (M) glycoprotein 150-158
COVID-19 / SARS-CoV-2A*03:01KVFRSSVLHSpike (S) glycoprotein 41-49
COVID-19 / SARS-CoV-2A*03:01QIYKTPPIKSpike (S) glycoprotein 787–795
COVID-19 / SARS-CoV-2A*11:014356BKTFPPTEPKSARS-CoV-2 Nucleocapsid protein 362-370 (confirmed epitope)
COVID-19 / SARS-CoV-2A*11:014691BVTNNTFTLKSARS-CoV-2 ORF1ab 808-816
COVID-19 / SARS-CoV-2A*11:014679BSVYAWNRKRSARS-CoV-2 Spike glycoprotein 349-357
COVID-19 / SARS-CoV-2A*11:01STFNVPMEKReplicase polyprotein 1ab 2600-2608
COVID-19 / SARS-CoV-2A*11:01ATEGALNTPKNucleocapsid (N) phosphoprotein 134–143
COVID-19 / SARS-CoV-2A*11:01ATSRTLSYYKMembrane (M) structural protein 171–180
COVID-19 / SARS-CoV-2A*11:01VTYVPAQEKSpike (S) glycoprotein 1065-1073
COVID-19 / SARS-CoV-2A*11:01GVYYHKNNKSpike (S) glycoprotein 142-150
COVID-19 / SARS-CoV-2A*11:01TLKSFTVEKSpike (S) glycoprotein 302-310
COVID-19 / SARS-CoV-2A*11:01GTHWFVTQRSpike (S) glycoprotein 1099-1107
COVID-19 / SARS-CoV-2A*11:01KSAAEASKKNucleocapsid (N) structural protein 249-257
COVID-19 / SARS-CoV-2A*11:01NSASFSTFKSpike (S) glycoprotein 370-378
COVID-19 / SARS-CoV-2A*11:01MTSCCSCLKSpike (S) glycoprotein 1219-1227
COVID-19 / SARS-CoV-2A*11:01RLFRKSNLKsurface glycoprotein 454-462
COVID-19 / SARS-CoV-2A*11:01LSYFIASFRMembrane (M) glycoprotein 93-101
COVID-19 / SARS-CoV-2A*11:01SAFAMMFVKReplicase polyprotein 1ab 3622-3630
COVID-19 / SARS-CoV-2A*24:024668QYIKWPWYISARS-CoV-2 Spike glycoprotein 1205-1213
COVID-19 / SARS-CoV-2A*24:024670VYIGDPAQLSARS-CoV-2 ORF1ab 5724-5732
COVID-19 / SARS-CoV-2A*24:024692NYNYLYRLFSARS-CoV-2 Spike glycoprotein 448-456
COVID-19 / SARS-CoV-2A*24:02NYMPYFFTLorf1ab polyprotein 2167-2175
COVID-19 / SARS-CoV-2A*24:02TYACWHHSIORF1ab polyprotein 6148-6156
COVID-19 / SARS-CoV-2A*24:02VYFLQSINFORF3a 112-120
COVID-19 / SARS-CoV-2A*24:02QFAPSASAFFNucleocapsid (N) protein 306-315
COVID-19 / SARS-CoV-2A*24:02KWPWYIWLGFSpike (S) glycoprotein 1211–1220
COVID-19 / SARS-CoV-2A*68:01ASAFFGMSRNucleocapsid (N) phosphoprotein 311-319
COVID-19 / SARS-CoV-2B*07:024351SPRWYFYYLSARS-CoV-2 Nucleocapsid protein 105-113 (confirmed epitope)
COVID-19 / SARS-CoV-2B*07:024694RARSVSPKLSARS-CoV-2 ORF7a 78-86
COVID-19 / SARS-CoV-2B*07:02IPRRNVATLReplicase polyprotein 1ab (ORF1ab) 5916–5924
COVID-19 / SARS-CoV-2B*07:02APSASAFFGMNucleocapsid phosphoprotein 308-317
COVID-19 / SARS-CoV-2B*07:02FPRGQGVPINucleocapsid 66-74
COVID-19 / SARS-CoV-2B*07:02KPRQKRTATNucleocapsid 257-265
COVID-19 / SARS-CoV-2B*07:02YPDKVFRSSVSpike glycoprotein 38-47
COVID-19 / SARS-CoV-2B*07:02LPKEITVATMembrane (M) glycoprotein 164-172
COVID-19 / SARS-CoV-2B*07:02LPVSMTKTSVSpike glycoprotein 727-736
COVID-19 / SARS-CoV-2B*07:02IPTNFTISVsurface glycoprotein 714-722
COVID-19 / SARS-CoV-2B*08:01DLKGKYVQIReplicase polyprotein 1ab 4344-4352
COVID-19 / SARS-CoV-2B*27:054354QRNAPRITFSARS-CoV-2 Nucleocapsid protein 9-17
COVID-19 / SARS-CoV-2B*35:01IPFAMQMAYspike (S) glycoprotein 896–904
COVID-19 / SARS-CoV-2B*35:01LPFNDGVYFsurface glycoprotein 84-92
COVID-19 / SARS-CoV-2B*40:014328MEVTPSGTWLSARS-CoV-2 Nucleocapsid protein 322-330 (confirmed epitope)
COVID-19 / SARS-CoV-2H-2Kb4549SIIAYTMSLSARS-CoV-2 Spike glycoprotein 691-699
COVID-19 / SARS-CoV-2H-2Kb4544VVLSFELLSARS-CoV-2 Spike glycoprotein 505-523
COVID-19 / SARS-CoV-2H-2KdIYQAGSTPCSpike glycoprotein 466-485
COVID-19 / SARS-CoV-2H-2LdFPQSAPHGVSpike glycoprotein 1052-1060
DengueA*02:012929TLYAVATTIDengue NS4b 40-48
DengueA*02:013931KLAEAIFKLDengue NS5 563-571
DengueA*02:013914ILIRTGLLVIDengue NS2b 97-106
DengueA*02:013918AIKRGLRTLDengue NS3 112-120
DengueA*02:013923LLLGLMILLDengue NS4a 56-64
DengueA*02:013928VLLLVTHYADengue NS4b 111-119
DengueA*02:01VTLLCLIPTVCapsid (C) protein 102-111
DengueA*02:01NIQTAINQVNon-structural protein 4B (NS4B DENV serotypes 1, 2, and 3) 3353-3361
DengueA*03:013913ELERAADVKDengue NS2b 52-60
DengueA*03:013910ARVSTVQQLTKDengue C 22-31
DengueA*03:013916ARIEPSWADVKDengue NS3 64-74
DengueA*03:013921ARVIDPRRCMKDengue NS3 422-431
DengueA*03:013929AKITAEWLWKDengue NS5 375-383
DengueA*03:01CVYNMMGKRGenome polyprotein DENV 4 2937-2945
DengueA*11:011843GTSGSPIINRDengue NS3 serotype 3&4 133-142
DengueA*11:012372GTSGSPIIDKDengue NS3 133-142
DengueA*11:012373GTSGSPIVNRNS3 serotype 1 133-142
DengueA*11:013459ATYGWNLVKDENV 1 NS5 2610-2618
DengueA*11:013460STYGWNIVKDENV 3 NS5 2607-2615
DengueA*11:013461STYGWNLVRDENV 2 NS5 2608-2616
DengueA*11:013906GTSGSPIVDRDengue NS3 serotype 2 133-142
DengueA*11:013907GTSGSPIADKDengue NS3 133-142
DengueA*11:014625GTSGSPIVDKDENV 2 NS3 1608-1617
DengueA*11:014626GTSGSPIINKDENV 4 NS3 1607-1617
DengueA*11:014627TIPPTAGILKDENV 2 Core 58-67
DengueA*11:014628TTLSRTSKKDENV 2 NS2a 1336-1344
DengueA*11:014629KTFDSEYVKDENV 2 Polyprotein 1863-1871
DengueA*11:014630KTFDSEYIKDENV 2 NS3 1863-1871
DengueA*11:014631KTFDTEYQKDENV 1 NS3 1864-1872
DengueA*11:014632ATVLMGLGKDENV 2 Polyprotein 2315-2323
DengueA*11:013910BRVSTVQQLTKDengue C 22-31
DengueA*11:013916BRIEPSWADVKDengue NS3 64-74
DengueA*11:013921BRVIDPRRCMKDengue NS3 422-431
DengueA*11:013929BKITAEWLWKDengue NS5 375-383
DengueA*24:022954QYSDRRWCFDengue NS3 557-565 (Singapore/S275/1990)
DengueA*24:024081TYGWNIVKLDENV 3 NS5 2608-2616
DengueA*24:024082TYGWNLVRLDENV 2 NS5 2609-2617
DengueA*24:024083TYGWNLVKLDENV 1, 4 NS5 2611-2619
DengueA*24:024633RYLEFEALGFDENV 3 NS5 2971-2980
DengueA*24:024634TYFQRVLIFDENV 2 M 261-269
DengueB*07:023909APTRVVAAEMDengue NS3 serotype 2 222-231
DengueB*07:02SPARLASAIGenome polyprotein (812-820)
DengueB*08:013915RIKQKGILDengue NS3 25-32
DengueB*08:013925LEKTKKDLDengue NS4a 6-13
DengueB*15:013912CLIPTAMAFDengue C 107-115
DengueB*35:013908TPEGIIPTLDengue NS3 500-508
DengueB*40:013924GEARKTFVELDengue NS3 528-537
EbolaA*02:01FLYDRLASTGlycoprotein 2 (GP2) 160-168
EbolaA*02:01ILFQRTFSIglycoprotein (GP) 25-33
EbolaA*02:01FLLQLNETISurface Glycoprotein (GP) 252-260
EbolaA*02:01RLAKLTEAINucleoprotein (NP) 401-409
EbolaA*02:01IIQAFEAGVNucleoprotein (NP) 56-64
EbolaA*02:01SLTDRELLLViral transcription-activation factor VP30 94-102
EbolaA*02:01GLMHNQDGLGlycoprotein (GP) 546-554
EbolaA*02:01SADSFLLMLnucleoprotein NP 69-77
EbolaA*02:01FLSFASLFLNucleoprotein (NP) 149-157
EbolaB*08:01FRLMRTNFLnucleoprotein NP (201-209)
EbolaB*35:01FPQLSAIALnucleoprotein NP 313-321
EBVA*01:01FLQRTDLSYEpstein-Barr nuclear antigen 3A (EBNA3A) 282-290
EBVA*02:011GLCTLVAMLEBV BMLF-1 259-267
EBVA*02:0142CLGGLLTMVEBV LMP-2 426-434
EBVA*02:01409YLLEMLWRLEBV LMP-1 125-133
EBVA*02:01410YLQQNWWTLEBV LMP1 159-167
EBVA*02:01462YVLDHLIVVEBV BRLF1 109-117
EBVA*02:01666FLYALALLLEBV LMP-2 356-364
EBVA*02:01872TLDYKPLSVEBV BMRF1 208-216
EBVA*02:011616LLDFVRFMGVEBV EBNA-3C 284-293
EBVA*02:012292FLDKGTYTLEBV BALF-4 276-284
EBVA*02:013462FMVFLQTHIEBV EBNA-1 (562-570)
EBVA*03:01727RLRAEAQVKEBV EBNA 3A 603-611
EBVA*03:011838RVRAYTYSKEBV BRLF1
EBVA*03:01QVATEGLAKTripartite terminase subunit UL28 homolog (BALF3) 540-548
EBVA*11:01199IVTDFSVIKEBV EBNA-4 416-424
EBVA*11:01508SSCSSCPLSKEBV LMP-2 340-349
EBVA*11:014183SSCSSCPLTKEBV LMP-2_EBVG
339-348
EBVA*11:01639ATIGTAMYKEBV BRLF1 134-142
EBVA*11:01726AVFDRKSDAKEBNA3B 399-408
EBVA*24:02420TYGPVFMCLEBV LMP-2 419-427
EBVA*24:02648PYLFWLAAIEBV LMP2 131-139
EBVA*24:02683TYGPVFMSLEBV LMP2 419-427
EBVB*07:0244RPPIFIRRLEBV EBNA-3A 247-255
EBVB*07:02647RPQGGSRPEFVKLEBV BMRF1 116-128
EBVB*07:022305QPRAPIRPIEBV EBNA-3C 881-889
EBVB*08:0173FLRGRAYGLEBV EBNA-3A 193-201
EBVB*08:01190RAKFKQLLEBV BZLF-1 190-197
EBVB*08:01489QAKWRLQTLEBV EBNA3A 158-166
EBVB*35:01107YPLHEQHGMEBV EBNA-3A 458-466
EBVB*35:01399EPLPQGQLTAYEBV BZLF-1 54-64
EBVB*35:013033HPVAEADYFEYEBV EBNA-1 407-417(4A)
EBVB*35:01LPPHDITPYEBNA-3C protein 98-106
EBVB*35:01VPGSETMCYEnvelope glycoprotein gp110 544–552
EBVB*40:01692IEDPPFNSLEBV LMP2 200-208
HAVA*02:012257LLYNCCYHVHepatitis A Virus polyprotein 2027-2034
HAVB*07:022164HPRLAQRILHepatitis A Virus polyprotein 1877-1885
HBVA*01:013939LLDTASALYCore 30-38
HBVA*02:0123FLPSDFFPSVHBV core antigen 18-27
HBVA*02:0127FLLTRILTIHBV envelope 183-191
HBVA*02:0128GLSPTVWLSVHBV surface antigen 185-194
HBVA*02:0131WLSLLVPFVHBV surface antigen 172-181
HBVA*02:0132FLLSLGIHLHBV polymerase 573-581
HBVA*02:01283FLPSDFFPSIHBV core 18-27 (subtype ADR4)
HBVA*02:01500VLHKRTLGLX 92-100
HBVA*02:01778GLSRYVARLHBV Pol 455-463
HBVA*02:011194YMDDVVLGAPolymerase 548-556
HBVA*02:012829KLHLYSHPIPol 502-510
HBVA*02:013934ELMTLATWVcore protein 64-72
HBVA*02:01ILLLCLIFLenvelope protein (L-HBsAg) 249-257
HBVA*02:01GLYSSTVPVpolymerase 61-69
HBVA*02:01LLVPFVQWFVLarge envelope protein (L-HBsAg) 338-347
HBVA*02:01SLNFLGGTTVLarge envelope protein / Surface antigen (HBsAg or preS/S region) 201-210
HBVA*02:01ILSTLPETTVCapsid protein / Core protein (HBcAg) 139–148
HBVA*02:01FLGGTPVCLLarge envelope protein (surface antigen / HBsAg) 204-212
HBVA*02:01FLPSDFFPAVcore antigen protein (HBcAg) 18-27
HBVA*02:01VLQAGFFLLLarge envelope protein / Hepatitis B surface antigen (HBsAg or Pre-S2/S protein) 177-185
HBVA*02:01STLPETTVVHepatitis B virus capsid / core protein (HBcAg) 141–149
HBVA*02:01GMLPVCPLILarge surface antigen / large envelope protein (Pre-S/S protein 276–284
HBVA*02:01VLEYLVSFGVCore/Capsid protein (HBcAg / nucleocapsid protein) 115-124
HBVA*02:01LVLLDYQGMLHBsAg protein 95-104
HBVA*02:01FLLAQFTSApolymerase (HBpol / Protein P) 513-521
HBVA*02:01AMSTTDLEAHepatitis B virus X protein (HBx) 102-110
HBVA*03:01YMDDVVLGAKDNA polymerase 538-547
HBVA*11:01377YVNVNMGLKHBV core antigen 88-96
HBVA*11:012659YVNTNMGLKCore 88-96
HBVA*11:013941STLPETTVVRRCore 141-151
HBVA*11:01VTKYLPLDKpolymerase 119-127
HBVA*11:01TVNENRRLKpolymerase protein (Protein P / POL) 100-108
HBVA*11:01TLWKAGILYKDNA polymerase 150-159
HBVA*11:01SVVRRAFPHProtein P 535-543
HBVA*24:02378EYLVSFGVWHBV core 117-125
HBVA*24:02413KYTSFPWLLHBV polymerase 756-764
HBVA*24:023935FFPSIRDLLcore protein 23-31
HBVA*24:02KYTAFPWLLpolymerase (756-764)
HBVA*24:02PFLPLLPIFlarge envelope protein (surface antigen / HBsAg) 211-219
HBVB*07:02701LPSDFFPSVCore 19-27
HBVB*08:013937GLKILQLLexternal core Ag
HBVH-2Kb422ILSPFLPLLHBV surface antigen 208-216
HBVH-2Kb477VWLSVIWMHBV Surface antigen 190-197
HBVH-2Kb1431MGLKFRQLHBV core 93-100
HBVH-2KbVSAAFYHLP protein 425-442
HBVH-2KdKYLPLDKGIProtein P 121-129
HBVH-2KdHYFQTRHYLpolymerase 140-148
HBVH-2Kd529WYWGPSLYSIlarge envelope 362-371
HBVH-2Kd526SYVNTNMGLCore 87-95
HBVH-2Ld129IPQSLDSWWTSLHBV surface antigen 28-39
HCVA*01:01740ATDALMTGYHCV NS3 1435-1443
HCVA*01:011066ATDALMTGFHCV NS3 1436-1444
HCVA*02:012DLMGYIPAVHCV core 132-140
HCVA*02:013CINGVCWTVHCV NS3 1073-1081
HCVA*02:014YLLPRRGPRLHCV core 35-44
HCVA*02:0136VLSDFKTWLHCV NS5a 1987-1995
HCVA*02:0137ALYDVVTKLHCV NS5b 2594-2602
HCVA*02:0140KLVALGINAVHCV NS3 1406-1415
HCVA*02:01243KLSGLGLNAVHCV NS3 1406-1415
HCVA*02:01172LLFNILGGWVHCV NS4b 1807-1816
HCVA*02:01242KLSGLGINAVHCV NS3 1406-1415
HCVA*02:01491DLMGYIPLVHCV core 132-140
HCVA*02:01858CVNGVCWTVHCV NS3 1073-1081
HCVA*02:011094GLQDCTMLVHCV NS5B 2727-2735
HCVA*02:01KLTGLGLNAVNon-structural protein 3 (NS3) 1406-1415
HCVA*02:01SLMAFTAAVNon-structural protein region (NS4B) 1789–1797
HCVA*02:01KLVAMGINAVnon-structural protein 3 (NS3) 1406-1415
HCVA*02:01DLMGYIPVVC7A2 protein fragment
HCVA*02:01RLGPVQNEINon-structural protein 3 (NS3) helicase 601-609
HCVA*02:01CISGVCWTVnon-structural protein 3 (NS3) 1073-1081
HCVA*02:01NLPGCSFSIpolyprotein 168-176
HCVA*02:01TIGGVMWTVprotease-helicase 47-55
HCVA*02:01AVNGVMWTVNon-structural protein 3 (NS3) 1073-1081
HCVA*02:01WMNRLIAFAGenome polyprotein / NS4B protein 204-212
HCVA*02:01WLGNIIMFANS5B RNA-dependent RNA polymerase 2827–2835
HCVA*02:01WLGNIIMYAGenome polyprotein / Non-structural protein 5B (NS5B RNA polymerase) 2831-2839
HCVA*03:0135RVCEKMALYHCV NS5B 2588-2596
HCVA*03:01VTLTHPITKGenome polyprotein / Non-structural protein 4A (NS4A) 1635-1643
HCVA*03:01KTSERSQPRGenome polyprotein 51–59
HCVA*03:01QLFTFSPRRGenome polyprotein 289-297
HCVA*24:02415AYSQQTRGLHCV NS3 1031-1039
HCVB*07:02742GPRLGVRATHCV core 41-49
HCVB*07:02845DPRRRSRNLHCV core 111-119
HCVB*08:01721HSKKKCDELHCV NS3 1395-1403
HCVB*27:05871ARMILMTHFNS5B 2841-2849
HCVB*35:01565HPNIEEVALHCV NS3 1359-1367
HCVB*35:01942CPNSSIVYHCV E1 207-214
HCVB*40:01939REISVPAEILHCV NS5a 2266-2275
HCVH-2Db791GAVQNEVTLHCV NS3 1629-1637
HDVA*02:01KLEEENPWLLarge delta antigen 43-51
HDVA*02:01KLEDDNPWLlarge delta antigen 43-51
HDVB*35:01FPWDILFPSlarge hepatitis delta antigen (L-HDAg) 194-202
HDVB*35:01FPWDILFPAlarge delta antigen 194-202
HEVA*02:01GLLDFALELopen reading frame 2 (ORF2) 166-174
HEVA*02:01SLFWNEPAIOpen Reading Frame 1 (ORF1) 1122-1130
HEVA*02:01LLWNTVWNMORF1 non-structural polyprotein 1527–1535
HHVB*08:01MAREKNDLHHV-6 U53 proteinase 431-438
HHVB*08:01TNKIKEQLHHV-6 U31 tegument protein 1135-1142
HHVB*08:01EFKSKFSTLHHV-6A Immediate-Early 1 (IE-A / IE1) 1489-1497
HHVB*08:01FEKERFLFLHHV-6 capsid assembly and DNA maturation 233-241
HHVB*08:01NVKHKKNPLHHV6 DNA-binding protein (DBP) 757-765
HHVB*08:01DFKSKYLTLHHV-6B U86 Immediate-early protein 2 (IE2) 314-322
HHVB*08:01EMRLRMILHHV-6B Protein U26 open reading frame (ORF) 92-99
HHVB*08:01VVKGKVLSIHHV-6 major DNA binding protein 1008-1016
HHvB*08:01QTRQKFHLHHV-6 major DNA binding protein 110-117
HHVB*08:01EARRRLAEMHHV-6 U3 257-265
HHVB*08:01EGRERILTVHHV-6B DNA replication protein U79/U80 105–113
HHVB*08:01RSKPRHMCVHHV-6 U7 protein 345-353
HIV/SIVA*01:01GTEEIKSLYgag protein 71-79
HIV/SIVA*02:0110SLYNTVATLHIV-1 gag p17 76-84
HIV/SIVA*02:0184ILKEPVHGVHIV-1 RT 476-484
HIV/SIVA*02:01174TLNAWVKVVHIV-1 gag p24 19-27
HIV/SIVA*02:01246KLTPLCVTLHIV-1 env gp120 90-98
HIV/SIVA*02:01430GLADQLIHLHIV-1 Vif 101-109
HIV/SIVA*02:01799LTFGWCFKLHIV-1 Nef 137-145
HIV/SIVA*02:011147FLGKIWPSGag 433-440
HIV/SIVA*02:011240ALVEMGHHAHIV Vpu 66-74
HIV/SIVA*02:011241RTLNAWVKVHIV Gag 150-158
HIV/SIVA*02:011244NVWATHACVHIV Env gp 67-7
HIV/SIVA*02:011537SLLNATAIAVHIV env 816-825
HIV/SIVA*02:013401SLFNTVATLHIV gag 77-85
HIV/SIVA*02:013402SLVKHHMYIHIV Vif 23-31
HIV/SIVA*02:013403VIYHYVDDLHIV Pol
HIV/SIVA*02:01SLYNLVATLGag polyprotein (p17) 77-85
HIV/SIVA*02:01SLYNTIAVLGag polyprotein (p17 matrix protein) 77–85
HIV/SIVA*02:01SLYNTVAFLGroup-specific antigen (Gag) core protein
HIV/SIVA*02:01AIIRILQQLViral protein R (Vpr) 59-67
HIV/SIVA*02:01SVYNTVATLGag matrix protein p17 (77–85)
HIV/SIVA*03:01109QVPLRPMTYKHIV-1 nef 73-82
HIV/SIVA*03:01194RLRPGGKKKHIV-1 gag p17 19-27
HIV/SIVA*03:011496AIFQSSMTKHIV pol 325-333
HIV/SIVA*03:01KIRLRPGGKGroup-specific antigen (Gag) polyprotein p17 matrix protein 18–26
HIV/SIVA*03:01AIFQCSMTKGag-Pol polyprotein 313–321
HIV/SIVA*11:011486AVDLSHFLKHIV nef 84-92
HIV/SIVA*11:011686ACQGVGGPGHKHIV gag p24
HIV/SIVA*24:02411RYPLTFGWCYHIV-1 Nef 134-143
HIV/SIVA*24:02419RYLKDQQLLHIV-1 gag gp41 67-75
HIV/SIVA*24:021805RYLRDQQLLHIV env
HIV/SIVA*24:023099RYPLTFGWCFHIV NEF 143-152
HIV/SIVA*24:023238RYPLTFGWHIV nef
HIV/SIVA*24:02KYQLKHIVWgag polyprotein 28-36
HIV/SIVA*29:023392LYNTVATLYHIV gag 79-86
HIV/SIVA*29:023395SFDPIPIHYHIV env 216-224
HIV/SIVA*29:023396SFNCRGEFFYHIV env 382-391
HIV/SIVB*07:02196IPRRIRQGLHIV-1 env gp120 848-856
HIV/SIVB*07:02257TPGPGVRYPLHIV-1 nef 128-137
HIV/SIVB*07:02877GPGHKARVLHIV gag p24 223-231
HIV/SIVB*08:01193FLKEKGGLHIV-1 nef 90-97
HIV/SIVB*08:01195GEIYKRWIIHIV-1 gag p24 261-269
HIV/SIVB*08:01879EIYKRWIIHIV p24 gag 128-135
HIV/SIVB*08:011536YLKDQQLLEnv 586-593
HIV/SIVB*15:011072RLRPGGKKKYHIV-1 p17 20-29
HIV/SIVB*27:05294KRWIILGLNKHIV-1 gag p24 265-274
HIV/SIVB*27:05874KRWIIMGLNKHIV-1 Gag p24 263-272
HIV/SIVB*27:052306GRAFVTIGKHIV-1 gp100 103-111
HIV/SIVB*35:01255NPDIVIYQYHIV-1 HIV-1 RT 328-336
HIV/SIVB*35:011211VPLDEDFRKYHIV-1 HIV-1 RT 273-282
HIV/SIVB*40:01840KEKGGLEGLHIV-1 Nef 92-100
HIV/SIVH-2Db719AAVKNWMTQTLSIV gag
HIV/SIVH-2DdIGPGRAFYTEnvelope glycoprotein gp160 precursor 314-322
HIV/SIVH-2DdIGPGRAFYTTEnvelope glycoprotein gp160 306-315
HIV/SIVH-2DdIGPGRAFYVVIV-1 envelope glycoprotein gp120 (V3 loop region)
HIV/SIVH-2Dd177RGPGRAFVTIHIV-1 IIIB gp120 318-327
HIV/SIVH-2Dd1684IGPGRAFYAHIV-1 US4 gp120 318-326
HIV/SIVH-2Kd176AMQMLKETIHIV-1 gag p24 199-207
HIV/SIVH-2Kd403AMQMLKDTIHIV gag p24 197-205
HIV/SIVMamu-A*011110CTPYDINQMSIV Gag 181-189
HIV/SIVMamu-A*021111YTSGPGIRYSIV Nef 159-167
HIV/SIVMamu-A*021112GSENLKSLYSIV Gag 71-79
HMPVA*02:01YMVQLPIFGVFusion glycoprotein F0 269-278
HPVA*01:01QVDYYGLYYRegulatory protein E2 151-159
HPVA*01:01ISEYRHYCYProtein E6 80-88
HPVA*02:0195YMLDLQPETTHPV 16 E7 11-20
HPVA*02:01658KLPQLCTELHPV 16 E6 18-26
HPVA*02:012103YMLDLQPETHPV E7 11-19
HPVA*02:012312MLDLQPETTHPV 16 E7 12-20
HPVA*02:01SLQDIEITCVE6 oncoprotein 24-33
HPVA*02:01KLPDLCTELE6 early oncoprotein 13-21
HPVA*02:01TLQDVSLEVYLE2 regulatory protein 93-103
HPVA*02:01YMLDLQAETE7 oncoprotein 11-19
HPVA*02:01VLLLWITAAE5 minor oncoprotein 46-54
HPVA*02:01YMLDLAPETE7 oncoprotein 11-19
HPVA*02:01AMLDLQPEToncoprotein E7 11-19
HPVA*02:01YMLDLQPEAE7 oncoprotein 11-19
HPVA*02:01YMADLQPETE7 oncoprotein 11-19
HPVA*02:01YMLALQPETE7 oncoprotein 11–19
HPVA*02:01FAFKDLFVVE6 oncoprotein of Alphapapillomavirus 7 47-55
HPVA*02:01YMLDLQPATE7 oncoprotein 11-19
HPVA*02:01YMLDAQPETE7 oncoprotein 11-19
HPVA*02:01YALDLQPETE7 oncoprotein 11-19
HPVA*02:01ICWGNQLFVMajor capsid protein L1 (HPV16 L1) 349-357
HPVA*03:012064KLCLRFLSKHPV 33 E6 64-72
HPVA*11:012067NTLEQTVKKHPV 33E6 86-94
HPVA*11:01SVYGDTLEKE6 Oncoprotein 84–92
HPVA*11:01GTTLEQQYNKE6 oncoprotein 92-101
HPVA*11:01TTLEQQYNKE6 oncoprotein 93–101
HPVA*24:023240VYDFAFRDLHPV16 E6
HPVB*07:022065KPTLKEYVLHPV 33 E7 5-13
HPVB*07:02WPTTPPRPIE4 protein 23-31
HPVB*35:01FAFRDLCIVYProtein E6 52-61
HPVH-2Db502HRAHYNIVTFHPV 16 E7 49-57
HPVH-2Db3404AGVDNRECIHPV L1 165-173
HPVH-2Kb2560EVYDFAFRDLHPV E6 48-57
HPVH-2KbCLKFYSKIE6 oncoprotein 73-80
HSVA*01:01ATDSLNNEYtegument protein VP11/12 354-362
HSVA*01:01FTDALGIDEYTegument protein VP16 479-488
HSVA*01:01SALPTNADLYTegument protein VP16 90-99
HSVA*02:011152VLMIKALELNon muscle Myosin-9 741-749
HSVA*02:011153QLFNHTMFINon-muscle Myosin 478-486
HSVA*02:013406QMARLAWEA1116-1124
HSVA*02:01TLLELVVSVSerine/threonine-protein kinase UL13 389-397
HSVA*02:01RILGVLVHLribonucleoside-diphosphate reductase large subunit (ICP6/ICP10) 425-433
HSVA*02:01ILIEGIFFAribonucleotide reductase subunit 2 184-192
HSVA*02:01FLWEDQTLLUL25 major capsid/tegument protein 367–375
HSVA*02:01SVYPYDEFVEnvelope glycoprotein B (gB) 280-288
HSVA*24:02AYLPRPVEFUL37 tegument protein 640–648
HSVH-2Db3405AAGPHNDMEIHSV p56 487-495
HSVH-2Dd3405BAGPHNDMEIHSV p56 487-495
HSVH-2Kb188SSIEFARLHSV-1 gp B 498-505
HSVH-2KbQTFDFGRLribonucleotide reductase 1 (RR1) 822-829
HSVH-2Kd3407TYWPVVSDI207-215
HTLVA*02:01200LLFGYPVYVHuman T-cell lymphotropic virus-1 (HTLV-1) tax 11-19
HTLVA*02:012309AVLDGLLSLHTLV bZIP factor 42-50
HTLVA*02:013408GLLSLEEELbZIP factor 26-34
HTLVA*24:021043SFHSLHLLFHTLV Tax 301-309
HTLVA*24:02FFQFCPLIFEnvelope glycoprotein (Env) 11–19
HTLVB*07:023400LPVSCPEDLbZIP factor 10-18
Human ParvovirusA*02:01GLCPHCINVB19 Non-capsid non-structural protein NS-1 613-621
Human ParvovirusA*24:02FYTPLADQFB19 Non-capsid protein NS-1 572-580
InfluenzaA*01:0176CTELKLSDYInfluenza A (PR8) NP 44-52
InfluenzaA*01:01540VSDGGPNLYInfluenza A PB1 591-599
InfluenzaA*02:017GILGFVFTLInfluenza A MP 58-66
InfluenzaA*02:012295ILGFVFTLTVInfluenza A MP 59-68
InfluenzaA*02:013409KLGEFYNQMMFlu BNP 85-94 (Influenza B)
InfluenzaA*03:0177ILRGSVAHKInfluenza A (PR8) NP 265-274
InfluenzaA*11:011513SIIPSGPLKInfluenza A MP 13-21
InfluenzaA*11:011720RMVLASTTAKInfluenza A MP1 178-187
InfluenzaA*11:011722KSMREEYRKInfluenza A MP2 70-78
InfluenzaA*24:02TYQWIIRNWRNA polymerase basic protein 2 (PB2) 549-557
InfluenzaB*07:021743QPEWFRNVLInfluenza A PB1 329-337
InfluenzaB*07:021744SPIVPSFDMInfluenza A NP 473-481
InfluenzaB*08:01ELRSRYWAIInfluenza A Nucleoprotein 380-388
InfluenzaB*27:05463SRYWAIRTRInfluenza A NP 383-391
InfluenzaB*27:05RSGAAGAAVKInfluenza A Nucleoprotein 175-184
InfluenzaH-2Db9ASNENMDAMInfluenza A (NT60) NP 366-374
InfluenzaH-2Db119ASNENMETMInfluenza A (PR8) NP 366-374
InfluenzaH-2Db3410SCLENFRAYVInfluenza A polymerease PA 224-233
InfluenzaH-2Db120SSLENFRAYVInfluenza A (PR8) Polymerase acidic protein 224-233
InfluenzaH-2DbASNENVETMInfluenza A NP366-374
InfluenzaH-2KbIGRFYIQMInfluenza A Nucleoprotein 36-43
InfluenzaH-2Kd98TYQRTRALVInfluenza A (PR8) NP 147-155
InfluenzaH-2Kd240IYSTVASSLInfluenza A HA 533-541
JC VirusA*02:01610SITEVECFLVP1 36-44
JC VirusA*02:01611ILMWEAVTLVP1 100-108
LASVA*02:01LLGTFTWTLGlycoprotein precursor (GPC / Glycoprotein GP) 258-266
LCMVA*02:012308ALPHIIDEVLCMV envelope gp 10-18
LCMVA*02:012310YLVSIFLHLLCMV envelope gp 447-455
LCMVA*02:013411SLNQTVHSLNP 69-77
LCMVH-2Db69KAVYNFATCLCMV GP1 33-41
LCMVH-2Db70FQPQNGQFILCMV NP 396-404
LCMVH-2Db142KAVYNFATMgp33 (C9M)
LCMVH-2Db186SGVENPGGYCLLCMV GP 276-286
LCMVH-2DbCSANNSHHYIPre-glycoprotein polyprotein GP complex 92-101
LCMVH-2Kb2076ISHNFCNLLCMV GP 118-125
LCMVH-2KbAVYNFATCglycoprotein precursor (GPC) 34-41
ListeriaH-2Kd178GYKDGNEYIListeria monocytogenes Listeriolysin 91-99
MalariaA*02:01314YLNKIQNSLPlasmodium falciparum CSP 334-342
MalariaH-2Db2697SQLLNAKYLPlasmodium berghei ANKA acid phosphatase 40-48
MalariaH-2DbSALLNVDNLPlasmodium berghei thrombospondin-related adhesion protein (TRAP) 130-138
MalariaH-2Kd376SYIPSAEKIPlasmodium berghei CSP 252-260
MalariaH-2Kd2290SYVPSAEQIPlasmodium CSP
MalariaH-2Kd771YYIPHQSSLPlasmodium falciparum Liver stage antigen 1671-1679
MCMVH-2DdSGPSRGRIIHypothetical protein MuHV1gpm18 346-354
MCMVH-2KbSTYTFVRTM38 protein 38-45
MCMVH-2KbSCLEFWQRM57 protein (816-824)
MeaslesA*02:01ILPGQDLQYVHemagglutinin (H) glycoprotein 516-525
MeaslesA*02:01FMYMSLLGVMatrix (M) protein 50-58
MeaslesA*02:01SMYRVFEVGVHemagglutinin (H) glycoprotein 250–259
MeaslesA*02:01KLWESPQEINonstructural C protein 84-92
MeaslesA*02:01LMIDRPYVLHemagglutinin (H) protein 30-38
MERS coronavirusH-2KdKYYSIIPHSIspike glycoprotein 292-300
MiHAgB*08:01ELQEKFLSLCentromere Protein F (CENPF) mitosin 1406-1414
Minor Histocompatibility AntigenA*01:01652IVDCLTEMYDRRFY 1521-1529
Minor Histocompatibility AntigenA*02:01175FIDSYICQVmiHAg H-Y (human SMCY) 311-319
Minor Histocompatibility AntigenA*02:01395YIGEVLVSVHA-2
Minor Histocompatibility AntigenA*02:01473VLHDDLLEAMinor Histocompatibility Antigen HA-1 137-145
Minor Histocompatibility AntigenA*02:01581RTLDKVLEVmiHAg HA-8
Minor Histocompatibility AntigenB*07:021113SPSVDKARAELMiHAg SMCY 1041-1051
Minor Histocompatibility AntigenH-2Db327WMHHNMDLImiHAg UTY 246-254
Minor Histocompatibility AntigenH-2Db328KCSRNRQYLmiHAg SMCY 738-746
Minor Histocompatibility AntigenH-2Kk269TENSGKDISMCY 1332-1339
Model AntigenH-2DbSSLQDGCFIRed fluorescent protein (drFP583) 111-119
Model AntigenH-2KbSIITFEKLOVA
Model AntigenH-2KbIIITFNDLPeptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase 644-651
Model AntigenH-2KbVQYAFGLPthyroglobulin precursor 2627-2635
Model AntigenH-2KbTNQDFIQRNischarin 600-608
Model AntigenH-2KdSYLPTAERLSynaptotagmin-12 292-300
Model AntigenH-2KdSYYDVKGDLGuanylyl cyclase C (GC-C)
Model AntigensH-2Kb93SIINFEKLOvalbumin 257-264
Model AntigensH-2Kb562LTFNYRNLHistocompatibility antigen 60 39-46
Model AntigensH-2Kb908KVVRFDKLOvalbumin (subdominant) 55-62
Model AntigensH-2Kb1803SIYRYYGL2C TCR
Model AntigensH-2Kd198HYLSTQSALEnhanced Green Fluorescent Protein (eGFP) 200-208
Model AntigensH-2Ld74TPHPARIGLE. coli beta-galactosidase 876-884
MousepoxH-2DdVGPSNSPIFdsRNA binding protein 140-148
MpoxH-2DdVGPSNSPTFRNA-binding protein OPG065 140-148
MuLVH-2Kb828KSPWFTTLMuLV env 622-629 (MC38)
MuLVH-2Ld398SPSYVYHQFMuLV env gp70 423-431
MumpsA*01:01YSDPNNHEVYlarge protein [Mumps virus genotype G] 1983-1992
MumpsA*02:01VMNQVIHGVHemagglutinin-neuraminidase (HN) glycoprotein 88-96
MumpsA*02:01LLDSSTTRVhemagglutinin-neuraminidase (HN) protein 505-513
MumpsA*02:01ALDQTDIRVMatrix (M) protein 108–116
MumpsA*02:01KLIAGVNYIMatrix (M) protein 161-169
MumpsB*07:02KPRTSTPVTEFphosphoprotein 142-152
MumpsB*07:02APIQGTNLLphosphoprotein 27-35
NEGATIVEA*01:01STEGGGLAYNegative Control
NegativeA*02:01N01NEGATIVENegative Control
NEGATIVEB*07:02GPAESAAGLNegative Control
NEGATIVEH-2KdSYSSAGASINegative Control
NEGATIVEH-2KdAYAGSAGSINegative Control
NorovirusA*02:013214TMFPHIIVDVNorovirus VP1 139-148
OtherA*02:01133LLDVPTAAVInterferon gamma inducible protein (GILT) 30 27-35
OtherA*02:01353RILGAVAKVVinculin 822-830
OtherA*02:01366LMWYELSKIKSHVF-8 gB.492-500
OtherA*02:013041ILEDIVLTLStreptococcus pyogenes Cas9 615-623
OtherA*02:01370TIHDIILECVAlpha papillomavirus 9 E6 Protein (22-31)
OtherA*02:01NLVPMIIHLImportin subunit alpha-3 protein (KPNA2-related) 368-376
OtherA*24:02KYMTAVVKLFHuman Cytochrome b-245 light chain (CYBA / p22-phox) 71-80
OtherB*07:02TPRNTYKMTSLProliferation marker protein Ki-67 844-854
OtherB*07:02SPREFRERALWASP homolog associated with actin, membranes and microtubules (WHAMM) 181-190
OtherB*07:02NPATPTSKLUPF0711 protein C18orf21 127-135
OtherB*07:02LPRVCGTTLTumor Necrosis Factor-beta (TNF-beta) 9-17
OtherB*07:02RPLTDNHRSLDNA damage-inducible protein 1 homolog 2 (DDI2) 52-61
OtherB*07:02SPDSSTPKLG2 and S phase-expressed protein 1 (GTSE1) 461-469
OtherB*07:02APRAVFPSIActin, alpha cardiac muscle 1 28-36
OtherB*07:02APPAEKAPVHistone H1.2 (12-20)
OtherB*07:02APRESAQAIProliferation marker protein Ki-67 2789-2797
OtherB*07:02LPRACWREARho GDP-dissociation inhibitor 2 (ARHGDIB)
OtherB*07:02APRRPPPPPRas and Rab interactor 3 276-284
OtherB*07:02RPWSGPSSVHelicase with zinc finger domain 2 (HELZ2)
OtherB*07:02TARPQSSALHomologous recombination OB-fold protein 126-134
OtherB*08:01TAKQKLDPAProliferation marker protein Ki-67 1437-1445
OtherB*35:01TPVDDRISLATP-dependent RNA helicase DDX20 DEAD-box helicase 20 or DP103 688-696
OtherE*01:01712VMAPRTLILC leader sequence peptide
OtherE*01:012355VMAPRTLVLA leader sequence peptide
OtherH-2Dk339RRLGRTLLLPolyoma virus middle T protein 389-397
OtherH-2Kb2331TSINFVKIMHV 524-431
OtherH-2Kd62RYLKNGKETLCw3 170-179
OtherH-2Kd458KYNKANVFLNRP-V7 superagonist peptide 8.3 Tg NOD mouse
OtherH-2Kd3414IYNVGQVSILeptospira
OtherH-2Ld
3051LPNWGKYVLRabies Glycoprotein (453-461)
OtherMamu-A*01LTPRPIIHAVACET(L1) ORF 1 845-854
Pichende virusH-2KbYTVKFPNMNucleoprotein 205-212
RSVA*02:01801KMLKEMGEVRSV NP 137-145
RSVA*02:01FLVNYEMKLNon-structural protein 2 (NS2) 61-69
RSVH-2Kd149KYKNAVTELRSV A strain F protein 85-93
RSVH-2Kd154SYIGSINNIRespiratory Syncytial Virus (RSV) M2 82-90
SARS-CoV-1A*02:01LLLNCLWSVSpike glycoprotein precursor (HCoV-299E) 77-85
Sendai VirusH-2Kb56FAPGNYPALSendai virus NP 324-332
SeVH-2KbARGNYPALNucleoprotein 324–332
SV40H-2Kb488VVYDFLKLSV40 T antigen 404-411
TBEVA*02:01ILLDNITTLNon-structural protein 3 (NS3) 1984-1992
Tick-Borne EncephalitisB*07:02LPLGHRLWLnon-structural protein NS4B 2496-2504
Toxoplasma gondiiH-2Kb2156SVLAFRRLtgd057 57-64
Toxoplasma gondiiB*07:02LPQFATAATdense granule protein 7 (GRA7) 20-28
Toxoplasma gondiiH-2LdIPAAAGRFFRhoptry protein 7 (ROP7) 161-169
Toxoplasma gondiiH-2LdSPMNGGYYMDense granule protein 4 (GRA4) 107-115
Trypanosoma CruziH-2Kb708ANYNFTLVTrypanosoma cruzi SP 536-543
Trypanosoma CruziH-2Kb964VNHRFTLVTrypanosoma cruzi ASP-2 553-560
Trypanosoma cruziH-2Kk3415TEWETGQIASP-2 320-327
TuberculosisA*01:01QSSFYSDWYAntigen 85-B precursor (85B) 115-123
TuberculosisA*02:01276KLIANNTRVMycobacterium bovis antigen 85-A 200-208
TuberculosisA*02:01324GLPVEYLQVMycobacterium bovis antigen 85-A 6-14
TuberculosisA*02:01619GILTVSVAV16 kDa
TuberculosisA*02:01620AMASTEGNVESAT-6
TuberculosisA*02:012221VLTDGNPPEV19 kDa
TuberculosisA*02:01KLQERLAKLHeat shock protein 65 (Hsp65, also known as 65 kDa chaperonin or GroEL homolog) 362-370
TuberculosisA*02:01FLLGLLFFVRv1490 hypothetical protein 325–333
TuberculosisA*02:01LMIGTAAAVAntigen 85B (Ag85B) 15-23
TuberculosisA*02:01FIYAGSLSALAntigen 85-B precursor (Ag85B or Rv1886c) 143-152
TuberculosisA*02:01GMGPSLIGLAntigen 85A (Ag85A) 198-206
TuberculosisA*02:01NLARTISEA6 kDa early secretory antigenic target (ESAT-6)
TuberculosisA*02:01KLVANNTRLSecretory protein Antigen 85B (Ag85B) 199-207
TuberculosisA*02:01GINTIPIALPPE family proteins 126-134
TuberculosisA*02:01MMARDTAEATB10.4 / EsxH (an ESAT-6-like secreted antigenic protein) 83-91
TuberculosisA*02:01FIYAGSLSAantigen 85B (Ag85B) 183-191
TuberculosisA*11:01AVMAGIVRAAKdiacylglycerol O-acyltransferase, partial 194-204
TuberculosisA*24:02KYIFPGGLLCyclopropane fatty acid synthase (Rv0447c) 386-394
TuberculosisA*24:02WYYQSGLSIAntigen 85-B (Ag85B) 100-108
TuberculosisA*24:02IYAGSLSALSecreted antigen Ag85B (184-192)
TuberculosisB*07:02GPSLIGLAMAntigen 85 complex 200-208
TuberculosisH-2Db547AIQGNVTSIMycobacterium tuberculosis ESAT-6 17-25
TuberculosisH-2Kb764IMYNYPAMMycobacterium tuberculosis TB10.4 4-11
TuberculosisH-2Kb769IMYNYPAMLMycobacterium tuberculosis TB10.4 4-12
TuberculosisH-2Kd1263VYAGAMSGLMtb85A 145-152
TuberculosisH-2Ld158MPVGGQSSFMycobacterium tuberculosis Ag85A 70-78
VacciniaA*02:01703KVDDTFYYVVaccinia virus Host range protein 2 74-82
VacciniaA*02:01978ILDDNLYKVVaccinia virus Copenhagen Protein G5 18-26
VacciniaA*02:01VLYDEFVTIA6L virion core/structural protein 6-14
VacciniaH-2Kb733TSYKFESVVaccinia virus WR epitope B8R 20-27
VacciniaH-2KbVIYIFTVRLProtein L2 53-61
Varicella Zoster VirusA*02:01995ALWALPHAAIE62 593-601
Varicella Zoster VirusA*02:01ILIEGIFFVRibonucleoside-diphosphate reductase small subunit 2 (RNR2) 156-164
Varicella Zoster VirusH-2DbRALINLIYCImmediate-early protein 62 (IE62) 527-535
Vesicular Stomatitis VirusH-2Kb373RGYVYQGLVSV NP 52
Vesicular Stomatitis VirusH-2Ld622MPYLIDFGLVSV N 275-283
VSBVA*02:01FLCLLIPGLNucleoprotein (N antigen) 82-90
VSVH-2DbFSLLNIYRIRNA-directed RNA polymerase L 262-270
VSVH-2KbNSYLYGALNucleoprotein 69-77
VSVH-2KbLGLRYKKLPhosphoprotein 248-255
West NileA*02:011320RLDDDGNFQLWest Nile Virus NY-99 polyprotein precursor (1452-1461)
West NileA*02:011322ATWAENIQVWest Nile virus NY-99 polyprotein precursor 3390-3398
West NileA*02:011327YTMDGEYRLWest Nile virus NY-99 polyprotein precursor 2023-2031
West NileH-2Db663LGMSNRDFLWest Nile Virus polyprotein 294-302
West Nile VirusA*02:011321SVGGVFTSVWNV envelope gp 430-438
West Nile VirusA*02:011324SLFGQRIEVWNV nonstructural protein 4B 15-23
Yellow FeverA*02:01VLAGWLFHVNon-structural protein 2B (NS2B) 1471-1479
Yellow FeverA*02:01LLWNGPIAVnon-structural protein 4B (NS4B)
Yellow Fever VirusA*02:012097LLWNGPMAVNS4B 214-222
Yellow Fever virusC*06:023942TRRFLPQILNS3 205-213
Yellow Fever VirusH-2Kb1182ATLTYRMLYellow Fever Virus 17D polyprotein 268-275
ZikaH-2DbIGVSNRDFVpolyprotein 294-302

(back to top)